論文・総説 - 原田　浩之

1. Tanaka K, Harada H, Kayamori K, Omura K. Chronic sclerosing sialadenitis of the submandibular gland as the initial symptom of IgG4-related disease: a case report. Tohoku J Exp Med. 2015.07; 236 (3): 193-198. ( PubMed, DOI )

2. Haobam Bijaya, Nozawa Takashi, Minowa-Nozawa Atsuko, Tanaka Misako, Oda Seiichiro, Watanabe Takayasu, Aikawa Chihiro, Maruyama Fumito, Nakagawa Ichiro. Rab17-mediated recycling endosomes contribute to autophagosome formation in response to Group A Streptococcus invasion. Cell Microbiol. 2014.12; 16 (12): 1806-1821. ( PubMed, DOI )

3. Mochizuki Yumi, Omura Ken, Harada Hiroyuki, Marukawa Eriko, Shimamoto Hiroaki, Tomioka Hirofumi. Functional outcomes and patient satisfaction after vascularized osteocutaneous scapula flap reconstruction of the mandible in patients with benign or cancerous tumours. Int J Oral Maxillofac Surg. 2014.11; 43 (11): 1330-1338. ( PubMed, DOI )

4. Kudoh Masanori, Harada Hiroyuki, Matsumoto Koshi, Sato Yuriko, Omura Ken, Ishii Yoshimasa. Methotrexate-associated lymphoproliferative disorder arising in the retromolar triangle and lung of a patient with rheumatoid arthritis. Oral Surg Oral Med Oral Pathol Oral Radiol. 2014.10; 118 (4): e105-e110. ( PubMed, DOI )

5. Takahara Namiaki, Imai Hideki, Nakagawa Satoshi, Sumikura Kanako, Tsushima Fumihiko, Omura Ken. Temporomandibular joint intermittent closed lock: clinic and magnetic resonance imaging findings. Oral Surg Oral Med Oral Pathol Oral Radiol. 2014.10; 118 (4): 418-423. ( PubMed, DOI )

6. Shirakawa Jumpei, Ezura Yoichi, Moriya Shuichi, Kawasaki Makiri, Yamada Takayuki, Notomi Takuya, Nakamoto Tetsuya, Hayata Tadayoshi, Miyawaki Atsushi, Omura Ken, Noda Masaki. Migration linked to FUCCI-indicated cell cycle is controlled by PTH and mechanical stress. J Cell Physiol. 2014.10; 229 (10): 1353-1358. ( PubMed, DOI )

7. Mochizuki Yumi, Omura Ken, Harada Hiroyuki, Marukawa Eriko, Shimamoto Hiroaki, Tomioka Hirofumi. Functional outcomes with dental prosthesis following simultaneous mandibulectomy and mandibular bone reconstruction. J Prosthodont Res. 2014.10; 58 (4): 259-266. ( PubMed, DOI )

8. Omura Ken. Current status of oral cancer treatment strategies: surgical treatments for oral squamous cell carcinoma. Int J Clin Oncol. 2014.06; 19 (3): 423-430. ( PubMed, DOI )

9. Matsukawa Sho, Morita Kei-ichi, Negishi Ayako, Harada Hiroyuki, Nakajima Yusuke, Shimamoto Hiroaki, Tomioka Hirofumi, Tanaka Kae, Ono Masaya, Yamada Tesshi, Omura Ken. Galectin-7 as a potential predictive marker of chemo- and/or radio-therapy resistance in oral squamous cell carcinoma. Cancer Med. 2014.04; 3 (2): 349-361. ( PubMed, DOI )

10. Yamamoto Shinsuke, Inoue Jun, Kawano Tatsuyuki, Kozaki Ken-ichi, Omura Ken, Inazawa Johji. The impact of miRNA-based molecular diagnostics and treatment of NRF2-stabilized tumors. Mol Cancer Res. 2014.01; 12 (1): 58-68. ( PubMed, DOI )

11. Rushatamukayanunt Pradit, Morita Kei-ichi, Matsukawa Sho, Harada Hiroyuki, Shimamoto Hiroaki, Tomioka Hirofumi, Omura Ken. Lack of association between high-risk human papillomaviruses and oral squamous cell carcinoma in young Japanese patients. Asian Pac J Cancer Prev. 2014; 15 (10): 4135-4141. ( PubMed )

12. Kudoh Masanori, Harada Hiroyuki, Sato Yuriko, Omura Ken, Ishii Yoshimasa. A case of Basal cell adenoma of the upper lip. Case Rep Med. 2014; 2014 795356. ( PubMed, DOI )

13. Kudoh Masanori, Harada Hiroyuki, Omura Ken, Ishii Yoshimasa. Epidermoid cyst arising in the submandibular region. Case Rep Med. 2013; 2013 419289. ( PubMed, DOI )

14. Yu Oikawa , Rika Noji , Hiroaki Shimono , Rikuka Shimizu , Naoya Kinoshita , Naoto Nishii , Takuma Kugimoto , Takeshi Kuroshima , Hiroyuki Harada. A study on direct metastasis to levels III, IV in oral tongue squamous cell carcinoma Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology. 2025.03; 37 (3): 446-449. ( DOI )

15. Noji R, Tohyama K, Nakamura S, Naito T, Oikawa Y, Kuroshima T, Tomioka H, Michi Y, Ikeda S, Asakage T, Miura N, Hamamoto Y, Harada H, Kano Y. Dynamic Changes in Circulating Tumor DNA During Immunotherapy for Head and Neck Cancer: SHIZUKU-HN Study International Journal of Molecular Sciences. 2024.12; 26 (1): 235. ( DOI )

16. Okuyama K, Yanamoto S. Saliva in Balancing Oral and Systemic Health, Oral Cancer, and Beyond: A Narrative Review Cancers. 2024.12; 16 (24): 4276. ( PubMed, DOI )

17. Mito S, Miyajima M, Tomioka H, Sato H, Takeuchi T, Muto H, Kabasawa Y, Harada H, Eguchi K, Kato S, Kano M. Postoperative Delirium Prediction Based on Preoperative Electrocardiogram and Electroencephalogram 2024 Asia Pacific Signal and Information Processing Association Annual Summit and Conference (APSIPA ASC). 2024.12; ( DOI )

18. Matsumura T, Aida J, Abe Y, Oikawa Y, Kuroshima T, Harada H, Maeda S. Obesity and postoperative flap complications in maxillofacial reconstruction surgery ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY. 2024.12; in press

19. Kim CY, Takeshita Y, Kugimoto T, Harada H, Park JS, Tubbs RS, Iwanaga J. Anatomy of the Buccal Space: Surgical and Radiological Perspectives. J Craniofac Surg. 2024.10; 35 (7): 1972-1976. ( PubMed, DOI )

20. Hirai H, Kinoshita N, Nishii N, Oikawa Y, Kugimoto T, Kuroshima T, Tomioka H, Michi Y, Sumita Y, Tomihara K, Harada H. Treatment strategies for patients over 80 years of age with oral squamous cell carcinoma. Surg Oncol. 2024.09; 57 102146. ( PubMed, DOI )

21. Otsuru M, Yamakawa N, Kirita T, Yamada SI, Kurita H, Kugimoto T, Harada H, Hasegawa T, Akashi M, Takeshita A, Uzawa N, Umeda M, Yanamoto S, Yamada T. Efficacy and safety of molecularly targeted agents and immune checkpoint inhibitors for unresectable or recurrent/metastatic oral cancer in Japan. J Dent Sci. 2024.07; 19 (3): 1628-1637. ( PubMed, DOI )

22. Ibi H, Takahashi K, Harada H, Watabe T, Podyma-Inoue KA. Transforming growth factor-β signals promote progression of squamous cell carcinoma by inducing epithelial-mesenchymal transition and angiogenesis. Biochem Biophys Res Commun. 2024.06; 714 149965. ( PubMed, DOI )

23. Suenaga M, Yamauchi S, Morikawa R, Noji R, Kano Y, Tokunaga M, Kinugasa Y. Chemotherapy and COVID-19 Vaccination in Patients With Gastrointestinal Cancer in vivo. 2024.05; 38 (3): 1278-1284. ( DOI )

24. Yamaguchi K, Okumura T, Oikawa Y, Nakagawa K, Yoshimi K, Harada H, Tohara H. Effect of oral intake initiation-establishment interval on hospital stay after oral cancer surgery Oral Diseases. 2024.05;

25. Kuroshima T, Kitagawa Y, Sato J, Watanabe S, Asaka T, Abe T, Harada H, Hirata K, Kuge Y. Maximum standardized uptake value in 11C-methionine positron emission tomography may predict the prognosis of patients with oral squamous cell carcinoma. Odontology. 2024.05; ( PubMed, DOI )

26. Iwasaki T, Harazono Y, Fukawa Y, Kaida A, Kayamori K, Sasaki Y, Harada H, Yoda T. Retrospective analysis of odontogenic myxoma and odontogenic myxofibroma in the oral and maxillofacial region: a fibrous tissue-related differentiation. Br J Oral Maxillofac Surg. 2024.02; ( PubMed, DOI )

27. Tokizaki S, Podyma-Inoue KA, Matsumoto T, Takahashi K, Kobayashi M, Ibi H, Uchida S, Iwabuchi S, Harada H, Hashimoto S, Miyazono K, Shirouzu M, Watabe T. Inhibition of transforming growth factor-β signals suppresses tumor formation by regulation of tumor microenvironment networks Cancer Science. 2024.01; 115 (1): 211-226. ( DOI )

28. Takahiro Naito, Rika Noji, Takuma Kugimoto, Takeshi Kuroshima, Hirofumi Tomioka, Shun Fujiwara, Mitsukuni Suenaga, Hiroyuki Harada, Yoshihito Kano. The Efficacy of Immunotherapy and Clinical Utility of Comprehensive Genomic Profiling in Adenoid Cystic Carcinoma of Head and Neck. Medicina (Kaunas). 2023.12; 59 (12): 2111. ( PubMed, DOI )

29. Takeda D, Kurita H, Kashima Y, Hasegawa T, Miyakoshi M, Yamada SI, Yamamura Y, Soutome S.. Is withdrawl of antiresorptive agents necessary before and after tooth extraction? A systematic review. Clin Oral Invest. 2023.12; 28 (1): 38. ( PubMed, DOI )

30. Shiori Tokizaki, Katarzyna A Podyma-Inoue, Takehisa Matsumoto, Kazuki Takahashi, Miho Kobayashi, Haruka Ibi, Shizuka Uchida, Sadahiro Iwabuchi, Hiroyuki Harada, Shinichi Hashimoto, Kohei Miyazono, Mikako Shirouzu, Tetsuro Watabe. Inhibition of transforming growth factor-β signals suppresses tumor formation by regulation of tumor microenvironment networks. Cancer Sci. 2023.11; ( PubMed, DOI )

31. Tomioka H, Nishii H, Oikawa Y, Kugimoto T, Kuroshima T, Hirai H, Kayamori K, Kaida A, Miura M, Harada H. Clinicopathological analysis of 134 patients with squamous cell carcinoma of the mandibular gingiva Heliyon. 2023.11; 10 (1): e23120. ( PubMed, DOI )

32. Kinoshita N, Hirai H, Fukawa Y, Yamagata Y, Kashima Y, Sato M, Ikeda T, Harada H. A case of dentinogenic ghost cell tumor of the mandible with a review of the literature J Oral Maxillofac Surg Med Pathol. 2023.11; 35 (6): 545-549. ( DOI )

33. Takuma Kugimoto, Naoto Nishii, Yu Oikawa, Takeshi Kuroshima, Hideaki Hirai, Hirofumi Tomioka, Yasuyuki Michi, Kou Kayamori, Junichiro Sakamoto, Joe Iwanaga, R Shane Tubbs, Tohru Ikeda, Masahiko Miura, Hiroyuki Harada. Invasion of the bucco-mandibular space by oral squamous cell carcinoma: histopathological analysis of invasion pattern. Front Oncol. 2023.10; 13 1168376. ( PubMed, DOI )

34. Sato J, Kodaira M, Harada H, Iguchi H, Yoshida T, Shibata H, Diagnosis and treatment of bone metastasis: comprehensive guideline (the 2nd Edition) developing group. Efficacy and safety of bone management agents administered at 12 weeks vs. 4 weeks in patients with bone metastases: A systematic review. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners. 2023.10; 10781552231203720. ( PubMed, DOI )

35. Okuyama K, Fukushima H, Naruse T, Yanamoto S. Cell-in-cell structure in cancer: evading strategies from anti-cancer therapies Front Oncol. 2023.09; 13 1248097. ( PubMed, DOI )

36. Akihiro Homma, Mizuo Ando, Nobuhiro Hanai, Hiroyuki Harada, Yoshitaka Honma, Tomonori Kanda, Satoshi Kano, Daisuke Kawakita, Naomi Kiyota, Yoshiyuki Kizawa, Masahiro Nakagawa, Takenori Ogawa, Hirotaka Shinomiya, Takeshi Shinozaki, Motoyuki Suzuki, Tetsuya Tsuji, Koichi Yasuda, Sadamoto Zenda, Takeshi Kodaira, Tadaaki Kirita, Ken-Ichi Nibu. Summary of Japanese clinical practice guidelines for head and neck cancer - 2022 update edited by the Japan society for head and neck cancer. Auris Nasus Larynx. 2023.07; S0385-8146 (23): 00140-2. ( PubMed, DOI )

37. Akaike Y, Morita K, Sakamoto K, Tsushima F, Kayamori K, Maruta N, Yamazaki K, Anzai E, Tonouchi E, Harada H, Ikeda T, Yoda T.. 口腔扁平苔癬様病変に伴う海綿状態の機械学習を使用した自動検出 Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology. 2023.07; 35 (4): 368-374. ( DOI 医中誌 )

38. Pissacha Daroonpan, Ryo Ouchi, Chenyang Zhang, Shigenori Nagai, Naoto Nishii, Yoshihisa Kashima, Fumihiko Tsushima, Hiroyuki Harada, Miwako Hamagaki, Tohru Ikeda, Jun Aida, Ruchadaporn Kaomongkolgit, Miyuki Azuma. Personal immune profiles: Diversity and prognostic value for oral tongue squamous cell carcinoma evaluated by comprehensive immune parameter analyses with multiplex immunofluorescence. Oral Oncol. 2023.06; 143 106458. ( PubMed, DOI )

39. Ito K, Tokura S, Takazawa I, Yoshida N, Nakanishi T, Akiyama K, Onuma Y, Adachi T, Harada H, Nojima H, Miura M, Yoshimura R, Kabasawa Y. Clinical investigation of use of Episil® oral solution in oral mucositis during radiotherapy for head and neck cancer. Heliyon. 2023.05; 9 (6): e15869. ( PubMed, DOI )

40. Okuyama K, Naruse T, Yanamoto S. Tumor microenvironmental modification by the current target therapy for head and neck squamous cell carcinoma J Exp Clin Cancer Res. 2023.05; 42 (1): 114. ( PubMed, DOI )

41. Hideaki Hirai, Naoto Nishii, Yu Oikawa, Toshimitsu Ohsako, Takuma Kugimoto, Takeshi Kuroshima, Hirofumi Tomioka, Yasuyuki Michi, Kou Kayamori, Tohru Ikeda, Hiroyuki Harada. Buccinator muscle invasion is a risk factor for cervical lymph node metastasis in squamous cell carcinoma of the buccal mucosa: A retrospective study. Oncol Lett. 2023.04; 25 (6): 226. ( PubMed, DOI )

42. Okuyama K, Yanamoto S. Oral Bacterial Contributions to Gingival Carcinogenesis and Progression Cancer Prev Res. 2023.04; 16 (4): 199-209. ( PubMed, DOI )

43. Heath BR, Gong W, Taner HF, Broses L, Okuyama K, Cheng W, Jin M, Fitzsimonds ZR, Manousidaki A, Wu Y, Zhang S, Wen H, Chinn SB, Bartee E, Xie Y, Moon JJ, Lei YL. Saturated fatty acids dampen the immunogenicity of cancer by suppressing STING Cell Rep. 2023.04; 42 (4): 112303. ( PubMed, DOI )

44. Atsushi Uesugi, Fumihiko Tsushima, Youji Miyamoto, Hiroyuki Harada. Pollen Food Allergy Syndrome Caused by Japanese Radish: A Case Report. Indian J Dermatol. 2023.02; 68 (1): 123. ( PubMed, DOI )

45. Okuyama K, Suzuki K, Yanamoto S. Relationship between Tumor Budding and Partial Epithelial-Mesenchymal Transition in Head and Neck Cancer Cancers. 2023.02; 15 (4): 1111. ( PubMed, DOI )

46. Misako Tanaka, Hiroyuki Harada, Hiroshi Kimura. The role of H3K9me3 in oral squamous cell carcinoma. Biochem Biophys Res Commun. 2023.01; 640 56-63. ( PubMed, DOI )

47. Hirai Hideaki, Kayamori Kou, Noji Rika, Kuroshima Takeshi, Ikeda Tohru, Harada Hiroyuki. 軟口蓋に孤立性の口腔内表在性血管粘液腫が生じた稀な1症例(A rare case of solitary intraoral superficial angiomyxoma arising in the soft palate) Journal of Oral Science. 2023.01; 65 (1): 69-71. ( 医中誌 )

48. Kinoshita N, Tomioka H, Oikawa Y, Fukawa Y, Ikeda T, Harada H. A case of sclerosing odontogenic carcinoma of the mandible with a review of the literature. Journal of oral science. 2023; 65 (4): 281-283. ( PubMed, DOI )

49. Kugimoto T, Yamagata Y, Ohsako T, Hirai H, Nishii N, Kayamori K, Ikeda T, Harada H.. Massive low-grade myxoid liposarcoma of the floor of the mouth: A case report and review of literature. World J Clin Cases. 2022.12; 10 (34): 12742-12749. ( PubMed, DOI )

50. Ohyama Y, Yamashiro M, Michi Y, Uzawa N, Myo K, Sonoda I, Sumino J, Miura C, Mizutani M, Yamamoto D, Kayamori K, Yoda T. Determination of Significant Prognostic Factors for Maxillary Gingival Squamous Cell Carcinoma in 90 Cases Indian J Otolaryngol Head Neck Surg. 2022.12; 74 (3): 5930-5935. ( PubMed, DOI )

51. Nojima H, Kaida A, Harada H, Akiyama M, Miuraa M. Effect of Ablative Dose Irradiation on Redistribution and Radioresponse in a Mouse Xenograft Model Radiat Res. 2022.12; 198 (6): 632-638. ( PubMed, DOI )

52. Machitani M, Takei J, Kaneko MK, Ueki S, Ohashi H, Watashi K, Kato Y, Masutomi K. Development of novel monoclonal antibodies against nsp12 of SARS-CoV-2 Virol J. 2022.12; 19 (1): 213. ( PubMed, DOI )

53. Hirai H, Kayamori K, Noji R, Kuroshima T, Ikeda T, Harada H. A rare case of solitary intraoral superficial angiomyxoma arising in the soft palate. J Oral Sci. 2022.11; 65 (1): 69-71. ( PubMed, DOI )

54. Tsukamoto K, Tanahashi A, Harada H, Takaoka M, Sohara H. Development of a new HotBalloon™ ablation catheter equipped with a balloon surface temperature monitoring sensor for pulmonary vein isolation. J Med Eng Technol. 2022.11; 46 (8): 687-692. ( PubMed, DOI )

55. Nishii N, Hirotsu Y, Takahashi Y, Takagawa Y, Amemiya K, Oyama T, Mochizuki H, Furusawa-Nishii E, Harada H, Omata M. Observation of dynamic changes in neutrophil-to-lymphocyte ratio is useful for evaluating treatment response to nivolumab in PD-L1-negative advanced oral cancer J Oral Maxillofac Surg Med Pathol. 2022.11; 34 (6): 833-841. ( DOI )

56. Nojima H, Kaida A, Kuroshima T, Yoshimura RI, Miura M. Retrograde Migration of an Au-198 Grain to the Submandibular Gland Post Brachytherapy Treatment of Floor of Mouth Cancer Cureus. 2022.11; 14 (11): e31904. ( PubMed, DOI )

57. Nishii Naoto, Hirotsu Yosuke, Takahashi Yukinobu, Takagawa Yuki, Amemiya Kenji, Oyama Toshio, Mochizuki Hitoshi, Furusawa-Nishii Emi, Harada Hiroyuki, Omata Masao. PD-L1陰性の進行口腔癌において好中球・リンパ球比の動的変化を観察することはニボルマブへの治療反応を評価するのに役立つ(Observation of dynamic changes in neutrophil-to-lymphocyte ratio is useful for evaluating treatment response to nivolumab in PD-L1-negative advanced oral cancer) Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology. 2022.11; 34 (6): 833-841. ( 医中誌 )

58. Nojima H, Kaida A, Harada H, Akiyama M, Miuraa M. Effect of Ablative Dose Irradiation on Redistribution and Radioresponse in a Mouse Xenograft Model. Radiat Res. . 2022.10; ( DOI )

59. Takuya Komiyama, Takeshi Kuroshima, Takehito Sugasawa, Shin-Ichiro Fujita, Yuta Ikami, Hideaki Hirai, Fumihiko Tsushima, Yasuyuki Michi, Kou Kayamori, Fumihiro Higashino, Hiroyuki Harada. High expression of Sam68 contributes to metastasis by regulating vimentin expression and a motile phenotype in oral squamous cell carcinoma. Oncol Rep. 2022.10; 48 (4): 183. ( PubMed, DOI )

60. Otsuki Shuya, Hori Ryusuke, Shinohara Shogo, Kojima Tsuyoshi, Tamaki Hisanobu, Asato Ryo, Kitamura Morimasa, Ichimaru Kazuyuki, Kitani Yoshiharu, Kumabe Yohei, Honda Keigo, Tsujimura Takashi, Harada Hiroyuki, Ushiro Koji, Omori Koichi. 再発・転移性頭頸部扁平上皮癌に対するニボルマブ投与患者の実臨床での2年間の長期予後および予後因子(Real-world 2-year long-term outcomes and prognostic factors in patients receiving nivolumab therapy for recurrent or metastatic squamous cell carcinoma of the head and neck) Auris・Nasus・Larynx. 2022.10; 49 (5): 834-844. ( 医中誌 )

61. Yanamoto S, Michi Y, Otsuru M, Inomata T, Nakayama H, Nomura T, Hasegawa T, Yamamura Y, Yamada SI, Kusukawa J, Yamakawa N, Hasegawa O, Ueda M, Kitagawa Y, Hiraki A, Hasegawa T, Ohiro Y, Kobayashi W, Asoda S, Kobayashi T, Iino M, Fukuda M, Ishibashi-Kanno N, Kawaguchi K, Aijima R, Noguchi K, Okura M, Tanaka A, Sugiura T, Shintani Y, Yagihara K, Yamashiro M, Ota Y, Miyazaki A, Takeshita A, Kawamata H, Hiroshi I, Uchida K, Umeda M, Kurita H, Kirita T. Protocol for a multicentre, prospective observational study of elective neck dissection for clinically node-negative oral tongue squamous cell carcinoma (END-TC study) BMJ Open. 2022.09; 12 (9): e059615. ( PubMed, DOI )

62. Tsushima F, Sakurai J, Shimizu R, Kayamori K, Harada H. Oral lichenoid contact lesions related to dental metal allergy may resolve after allergen removal. J Dent Sci. 2022.07; 17 (3): 1300-1306. ( PubMed, DOI )

63. Rika Noji, Kohki Tohyama, Takuma Kugimoto, Takeshi Kuroshima, Hideaki Hirai, Hirofumi Tomioka, Yasuyuki Michi, Akihisa Tasaki, Kazuchika Ohno, Yosuke Ariizumi, Iichiroh Onishi, Mitsukuni Suenaga, Takehiko Mori, Ryuichi Okamoto, Ryoichi Yoshimura, Masahiko Miura, Takahiro Asakage, Satoshi Miyake, Sadakatsu Ikeda, Hiroyuki Harada, Yoshihito Kano. Comprehensive Genomic Profiling Reveals Clinical Associations in Response to Immune Therapy in Head and Neck Cancer. Cancers (Basel). 2022.07; 14 (14): 3476. ( PubMed, DOI )

64. Xie CY, Satake-Ozawa M, Rashed F, Khan M, Ikeda M, Hayashi S, Sawada S, Sasaki Y, Ikeda T, Mori Y, Akiyoshi K, Aoki K. Perforated Hydrogels Consisting of Cholesterol-Bearing Pullulan (CHP) Nanogels: A Newly Designed Scaffold for Bone Regeneration Induced by RANKL-Binding Peptides and BMP-2 Int J Mol Sci. 2022.07; 23 (14): 7768. ( PubMed, DOI )

65. Okuyama K, Yanamoto S. TMEM16A as a potential treatment target for head and neck cancer J Exp Clin Cancer Res. 2022.06; 41 (1): 196. ( PubMed, DOI )

66. Hiromitsu Sato, Peng Chen, Maki Ashida, Yusuke Tsutsumi, Hiroyuki Harada, Takao Hanawa. Evaluation of cytocompatibility and osteoconductivity of Zr-14Nb-5Ta-1Mo alloy with MC3T3-E1 cells. Dent Mater J. 2022.05; 41 (3): 421-428. ( PubMed, DOI )

67. Sato Hiromitsu, Chen Peng, Ashida Maki, Tsutsumi Yusuke, Harada Hiroyuki, Hanawa Takao. MC3T3-E1細胞によるZr-14Nb-5Ta-1Mo合金の細胞適合性と骨伝導性の評価(Evaluation of cytocompatibility and osteoconductivity of Zr-14Nb-5Ta-1Mo alloy with MC3T3-E1 cells) Dental Materials Journal. 2022.05; 41 (3): 421-428. ( 医中誌 )

68. Harazono Y, Kayamori K, Sakamoto J, Akaike Y, Kurasawa Y, Tsushima F, Sasaki Y, Harada H, Yoda T. Retrospective analysis of schwannoma in the oral and maxillofacial region: clinicopathological characteristics and specific pathology of ancient change. Br J Oral Maxillofac Surg. 2022.04; S0266-4356 (21): 00262-X. ( PubMed, DOI )

69. Li G, Suzuki H, Takei J, Asano T, Sano M, Tanaka T, Harada H, Mizuno T, Ohishi T, Kawada M, Kaneko MK, Kato Y. Antitumor Activities in Mouse Xenograft Models of Canine Mammary Gland Tumor by Defucosylated Mouse-Dog Chimeric Anti-Epidermal Growth Factor Receptor Antibody (E134Bf). Monoclon Antib Immunodiagn Immunother. 2022.04; 41 (2): 53-58. ( PubMed, DOI )

70. Nanamiya R, Suzuki H, Takei J, Li G, Goto N, Harada H, Saito M, Tanaka T, Asano T, Kaneko MK, Kato Y. Development of Monoclonal Antibody 281-mG 2a-f Against Golden Hamster Podoplanin. Monoclon Antib Immunodiagn Immunother. 2022.04; 41 (6): 311-319. ( PubMed, DOI )

71. Goto N, Suzuki H, Ohishi T, Harakawa A, Li G, Saito M, Takei J, Tanaka T, Asano T, Sano M, Kawada M, Kaneko MK, Kato Y. Antitumor Activities in Mouse Xenograft Models of Canine Fibroblastic Tumor by Defucosylated Anti-EGFR Monoclonal Antibody Monoclon Antib Immunodiagn Immunother. 2022.04; 41 (2): 67-73. ( DOI )

72. Widyagarini A, Nishii N, Kawano Y, Zhang C, Azuma M. VSIG4/CRIg directly regulates early CD8+T cell activation through its counter-receptor in a narrow window Biochem Biophys Res Commun. 2022.04; 614 100-106. ( PubMed, DOI )

73. Takei J, Suzuki H, Asano T, Tanaka T, Kaneko MK, Kato Y. Development of a Novel Anti-mouse CCR4 Monoclonal Antibody (C4Mab-1) by N-terminal Peptide Immunization Monoclon Antib Immunodiagn Immunother. 2022.04; 41 (2): ( DOI )

74. Tran PX, Inoue J, Harada H, Inazawa J. Potential for reversing miR-634-mediated cytoprotective processes to improve efficacy of chemotherapy against oral squamous cell carcinoma. Mol Ther Oncolytics. 2022.03; 24 897-908. ( PubMed, DOI )

75. Matsuda Y, Yamashita T, Ye J, Yasukawa M, Yamakawa K, Mukai Y, Machitani M, Daigo Y, Miyagi Y, Yokose T, Oshima T, Ito H, Morinaga S, Kishida T, Minamoto T, Yamada S, Takei J, Kaneko MK, Kojima M, Kaneko S, Masaki T, Hirata M, Haba R, Kontani K, Kanaji N, Miyatake N, Okano K, Kato Y, Masutomi K. Phosphorylation of hTERT at threonine 249 is a novel tumor biomarker of aggressive cancer with poor prognosis in multiple organs J Pathol. 2022.03; 257 (2): 172-185. ( PubMed, DOI )

76. Terauchi Masahiko, Marukawa Eriko, Hyodo Katsuya, Iwasaki Takuya, Wada Akane, Harada Hiroyuki, Yoda Tetsuya. 下歯槽神経を温存しつつ行った歯原性粘液腫の保存的外科治療(Conservative surgical treatment of odontogenic myxoma with preservation of the inferior alveolar nerve) Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology. 2022.03; 34 (2): 156-163. ( 医中誌 )

77. Kaho Takada, Tomoki Chiba, Takayuki Miyazaki, Lisa Yagasaki, Ryo Nakamichi, Takanori Iwata, Keiji Moriyama, Hiroyuki Harada, Hiroshi Asahara. Single Cell RNA Sequencing Reveals Critical Functions of Mkx in Periodontal Ligament Homeostasis Front Cell Dev Biol. 2022.02; 10 795441. ( PubMed, DOI )

78. Li G, Suzuki H, Takei J, Saito M, Goto N, Uchida K, Nakagawa T, Harada H, Tanaka T, Asano T, Kaneko MK, Kato Y.. Immunohistochemical Analysis Using Monoclonal Antibody PMab-269 Against Steller Sea Lion Podoplanin. Monoclon Antib Immunodiagn Immunother. 2022.02; 41 (1): 39-44. ( PubMed, DOI )

79. Kawabata H, Suzuki H, Takei J, Kaneko MK, Kato Y. Epitope Mapping of an Anti-CD10 Monoclonal Antibody (MME/1870) using Enzyme-Linked Immunosorbent Assay Monoclon Antib Immunodiagn Immunother. 2022.02; 41 (1): ( DOI )

80. Nanamiya R, Takei J, Ohishi T, Asano T, Tanaka T, Sano M, Nakamura T, Yanaka M, Handa S, Tateyama N, Harigae Y, Saito M, Suzuki H, Kawada M, Kaneko MK, Kato Y. Defucosylated Anti-EGFR Monoclonal Antibody (134-mG2a-f) Exerts Antitumor Activities in Mouse Xenograft Models of Canine Osteosarcoma Monoclon Antib Immunodiagn Immunother. 2022.02; 41 (1): ( DOI )

81. Rika Noji, Yoshihito Kano, Hideaki Hirai, Iichiroh Onishi, Naoto Nishii, Ryoichi Yoshimura, Satoshi Miyake, Sadakatsu Ikeda, Hiroyuki Harada. MYC-PDL1 axis reduces sensitivity to nivolumab in recurrent head and neck squamous cell carcinoma. Oral Oncol. 2022.01; 124 105666. ( PubMed, DOI )

82. Yumi Mochizuki, Maiko Tsuchiya, Jun Oyama, Akane Wada, Takuma Kugimoto, Takeshi Kuroshima, Hideaki Hirai, Hirofumi Tomioka, Hiroyuki Harada, Tohru Ikeda, Takumi Akashi. Left supraclavicular (Virchow's) node metastasis detected before primary infradiaphragmatic tumor: a case series. J Med Case Rep. 2022.01; 16 (1): 33. ( PubMed, DOI )

83. Shimizu R, Tsushima F, Komiya R, Yamagata Y, Harada H. Fixed Drug Eruption Associated with Nonsteroidal Anti-Inflammatory Drugs for Menstrual Pain: A Case Report. Case Rep Dermatol. 2022.01; 14 (1): 6-11. ( PubMed, DOI )

84. Yasuyuki Michi, Hiroyuki Harada, Yu Oikawa, Kohei Okuyama, Takuma Kugimoto, Takeshi Kuroshima, Hideaki Hirai, Yumi Mochizuki, Hiroaki Shimamoto, Hirofumi Tomioka, Hirokazu Kachi, Jun-Ichiro Sakamoto, Kou Kayamori, Tetsuya Yoda. Clinical manifestations of diffuse large B-cell lymphoma that exhibits initial symptoms in the maxilla and mandible: a single-center retrospective study. BMC Oral Health. 2022.01; 22 (1): 20. ( PubMed, DOI )

85. Tsushima F, Sakurai J, Shimizu R, Harada H. A case report of oral lichenoid lesions related to cross-reactivity between nickel and palladium. Contact Derm. 2021.12; 85 (6): 700-701. ( PubMed, DOI )

86. Terasawa K, Kato Y, Ikami Y, Sakamoto K, Ohtake K, Kusano S, Tomabechi Y, Kukimoto-Niino M, Shirouzu M, Guan JL, Kobayashi T, Iwata T, Watabe T, Yokoyama S, Hara-Yokoyama M. Direct homophilic interaction of LAMP2A with the two-domain architecture revealed by site-directed photo-crosslinks and steric hindrances in mammalian cells. Autophagy. 2021.12; 17 (12): 4286-4303. ( PubMed, DOI )

87. Shimono H, Hirai H, Oikawa Y, Mochizuki Y, Kuroshima T, Tomioka H, Kayamori K, Ikeda T, Harada H. Metastatic tumors in the oral region: a retrospective chart review of clinical characteristics and prognosis. Oral Surg Oral Med Oral Pathol Oral Radiol. 2021.12; 132 (6): 648-652. ( PubMed, DOI )

88. Takei J, Suzuki H, Asano T, Li G, Saito M, Kaneko MK, Kato Y. Epitope Mapping of an Anti-CD20 Monoclonal Antibody (C20Mab-60) using Enzyme-Linked Immunosorbent Assay. Monoclon Antib Immunodiagn Immunother. 2021.12; 40 (6): 250-254. ( PubMed, DOI )

89. Takei J, Asano T, Li G, Saito M, Suzuki H, Kaneko MK, Kato Y. Epitope Mapping of an Anti-Human CCR9 Monoclonal Antibody (C9Mab-1) using Enzyme-Linked Immunosorbent Assay. Monoclon Antib Immunodiagn Immunother. 2021.12; 40 (6): 239-242. ( PubMed, DOI )

90. Asano T, Takei J, Suzuki H, Kaneko MK, Kato Y. Epitope Mapping of an Anti-HER2 Monoclonal Antibody (H2Mab-181) using Enzyme-Linked Immunosorbent Assay. Monoclon Antib Immunodiagn Immunother. 2021.12; 40 (6): 255-260. ( PubMed, DOI )

91. Asano T, Takei J, Furusawa Y, Saito M, Suzuki H, Kaneko MK, Kato Y. Epitope Mapping of an Anti-CD20 Monoclonal Antibody (C20Mab-60) using the HisMAP Method. Monoclon Antib Immunodiagn Immunother. 2021.12; 40 (6): 243-249. ( PubMed, DOI )

92. Li G, Ohishi T, Kaneko MK, Takei J, Mizuno T, Kawada M, Saito M, Suzuki H, Kato Y. Defucosylated Mouse–Dog Chimeric Anti-EGFR Antibody Exerts Antitumor Activities in Mouse Xenograft Models of Canine Tumors. Cells. 2021.12; 10 (12): 3599. ( PubMed, DOI )

93. Yoshimura R, Toda K, Watanabe H, Kaida A, Harada H, Asakage T, Miura M. Efficacy and Safety of Induction Chemotherapy and/or External Beam Radiotherapy Followed by Brachytherapy in Patients With Tongue Cancer. Anticancer Res. 2021.12; 41 (12): 6259-6266. ( PubMed, DOI )

94. Yuta Ikami, Kazue Terasawa, Kensaku Sakamoto, Kazumasa Ohtake, Hiroyuki Harada, Tetsuro Watabe, Shigeyuki Yokoyama, Miki Hara-Yokoyama. The two-domain architecture of LAMP2A regulates its interaction with Hsc70. Exp Cell Res. 2021.12; 411 (1): 112986. ( PubMed, DOI )

95. Okuyama K, Michi Y, Kashima Y, Tomioka H, Hirai H, Yokokawa M, Yamagata Y, Kuroshima T, Sato Y, Tsuchiya M, Kayamori K, Ikeda T, Harada H. Epithelial-Myoepithelial Carcinoma of the Minor Salivary Glands: Case Series with Comprehensive Review. Diagnostics. 2021.11; 11 (11): 2124. ( PubMed, DOI )

96. ティーラウォン・チャンヤーヌット, 坂本　啓, 布川裕規, 土谷麻衣子, 栢森　高, 明石　巧, 濱垣美和子, 富岡博文, 黒嶋雄志, 森田圭一, 原田浩之, 池田　通. 舌癌症例にみられるヒトパピローマウイルス(HPV)感染と無関係なp16免疫染色陽性反応. 口腔病学会雑誌. 2021.11; 88 (2-3): 115-126. ( 医中誌 )

97. Hayashi S, Sasaki Y, Kubo H, Sawada S, Kinoshita N, Marukawa E, Harada H, Akiyoshi K. Construction of Hybrid Cell Spheroids Using Cell Sized Cross-Linked Nanogel Microspheres as an Artificial Extracellular Matrix. ACS Appl Bio Mater. 2021.11; 4 (11): 7848-7855. ( PubMed, DOI )

98. ティーラウォン・チャンヤーヌット , 坂本 啓, 布川 裕規, 土谷 麻衣子, 栢森 高, 明石 巧, 濱垣 美和子, 富岡 博文, 黒嶋 雄志, 森田 圭一, 原田 浩之, 池田 通. 舌癌症例にみられるヒトパピローマウイルス(HPV)感染と無関係なp16免疫染色陽性反応(Immunohistochemical Positivity for p16 Unrelated to Human Papillomavirus(HPV) Infection in Lingual Squamous Cell Carcinomas) 口腔病学会雑誌. 2021.11; 88 (2-3): 115-126. ( 医中誌 )

99. Okuyama K, Yanamoto S, Michi Y, Shibata E, Tsuchiya M, Yokokawa M, Naruse T, Tomioka H, Kuroshima T, Shimamoto H, Ikeda T, Umeda M, Yoda T, Harada H. Multicenter retrospective analysis of clinicopathological features and prognosis of oral tongue squamous cell carcinoma in adolescent and young adult patients. Medicine. 2021.10; 100 (41): e27560. ( PubMed, DOI )

100. Harada H, Tomioka H, Hirai H, Kuroshima T, Oikawa Y, Nojima H, Sakamoto J, Kurabayashi T, Kayamori K, Ikeda T. MRI before biopsy correlates with depth of invasion corrected for shrinkage rate of the histopathological specimen in tongue carcinoma. Sci Rep. 2021.10; 11 (1): 20992. ( PubMed, DOI )

101. Kuroshima T, Onozato Y, Oikawa Y, Ohsako T, Kugimoto T, Hirai H, Tomioka H, Michi Y, Miura M, Yoshimura R, Harada H. Prognostic impact of lingual lymph node metastasis in patients with squamous cell carcinoma of the tongue: a retrospective study. Sci Rep. 2021.10; 11 (1): 20535. ( PubMed, DOI )

102. Takei J, Asano T, Suzuki H, Kaneko MK, Kato Y. Epitope mapping of the anti-CD44 monoclonal antibody (C44Mab-46) using alanine-scanning mutagenesis and surface plasmon resonance. Monoclon Antib Immunodiagn Immunother. 2021.10; 40 (5): 219-226. ( PubMed, DOI )

103. Shibata E, Morita KI, Kayamori K, Tange S, Shibata H, Harazono Y, Michi Y, Ikeda T, Harada H, Imoto I, Yoda T. Detection of novel fusion genes by next-generation sequencing-based targeted RNA sequencing analysis in adenoid cystic carcinoma of head and neck. Oral Surg Oral Med Oral Pathol Oral Radiol. 2021.10; 132 (4): 426-433. ( PubMed, DOI )

104. Terauchi M, Marukawa E, Hyodo K, Iwasaki T, Wada A, Harada H, Yoda T. Conservative surgical treatment of odontogenic myxoma with preservation of the inferior alveolar nerve. J Oral Maxillofac Surg Med Pathol. 2021.10; ( DOI )

105. Fujimura N, Hosokawa K, Obara H, Igari K, Akamatsu D, Matsumoto H, Asami A, Shibutani S, Akiyoshi T, Nunokawa M, Harada H, Inoue K, Koya A, Furuyama T, Sagara D, Shintani T, Yamaoka T, Akiyama Y, Inoue Y, Hoshina K. Incidence, diagnosis and treatment of popliteal artery entrapment syndrome in current vascular practice in Japan. Cardiovascular intervention and therapeutics. 2021.10; 36 (4): 506-513. ( PubMed, DOI )

106. Harada H, Shimamoto H, Oikawa Y, Kuroshima T, Tomioka H, Hirai H, Tsushima F, Michi Y. Mandibular Reconstruction with Scapular Systems: A Single-Center Case Series Involving 208 Flaps. Plast Reconstr Surg. 2021.09; 148 (3): 625-634. ( PubMed, DOI )

107. Mochizuki Y, Marukawa E, Harada H, Kinoshita N, Nakatani R, Oikawa Y, Hirai H, Tomioka H, Yoda T, Nakamura S, Kurabayashi T. Postoperative morphological changes over time of vascularized scapular bone used for mandibular reconstruction: A retrospective cohort study. J Plast Reconstr Aesthet Surg. 2021.09; 74 (9): 1984-1990. ( PubMed, DOI )

108. Kaida A, Yamamoto S, Parrales A, Young ED, Ranjan A, Alalem MA, Morita KI, Oikawa Y, Harada H, Ikeda T, Thomas SM, Diaz FJ, Iwakuma T. DNAJA1 promotes cancer metastasis through interaction with mutant p53. Oncogene. 2021.08; 40 (31): 5013-5025. ( PubMed, DOI )

109. Asano T, Ohishi T, Takei J, Nakamura T, Nanamiya R, Hosono H, Tanaka T, Sano M, Harada H, Kawada M, Kaneko MK, Kato Y. Anti-HER3 monoclonal antibody exerts antitumor activity in a mouse model of colorectal adenocarcinoma. Oncol Rep. 2021.08; 46 (2): 173. ( PubMed, DOI )

110. Asano T, Kaneko MK, Takei J, Tateyama N, Kato Y. Epitope Mapping of the Anti-CD44 Monoclonal Antibody (C44Mab-46) Using the REMAP Method. Monoclon Antib Immunodiagn Immunother. 2021.08; 40 (4): 156-161. ( PubMed, DOI )

111. Tanaka T, Asano T, Sano M, Takei J, Hosono H, Nanamiya R, Tateyama N, Kaneko MK, Kato Y. Epitope Mapping of the Anti-California Sea Lion Podoplanin Monoclonal Antibody PMab-269 using Alanine-scanning Mutagenesis and ELISA. Monoclon Antib Immunodiagn Immunother. 2021.08; 40 (4): 196-200. ( PubMed, DOI )

112. Takei J, Asano T, Tanaka T, Sano M, Hosono H, Nanamiya R, Tateyama N, Saito M, Suzuki H, Harada H, Kaneko MK, Kato Y. Development of a Novel Anti-HER2 Monoclonal Antibody H2Mab-181 for Gastric Cancer. Monoclon Antib Immunodiagn Immunother. 2021.08; 40 (4): 168-176. ( PubMed, DOI )

113. Aragaki T, Tomomatsu N, Michi Y, Hosaka H, Fukai Y, Iijima M, Yoda T. Ramucirumab-related Oral Pyogenic Granuloma: A Report of Two Cases. Intern Med. 2021.08; 60 (16): 2601-2605. ( PubMed, DOI )

114. Tateyama N, Asano T, Ohishi T, Takei J, Hosono H, Nanamiya R, Tanaka T, Sano M, Saito M, Kawada M, Kaneko MK, Kato Y. An Anti‐HER2 Monoclonal Antibody H2Mab‐41 Exerts Antitumor Activities in Mouse Xenograft Model using Dog HER2‐overexpressed Cells. Monoclon Antib Immunodiagn Immunother. 2021.08; 40 (4): 184-190. ( PubMed, DOI )

115. Tateyama N, Nanamiya R, Ohishi T, Takei J, Nakamura T, Yanaka M, Hosono H, Saito M, Asano T, Tanaka T, Sano M, Kawada M, Kaneko MK, Kato Y. Defucosylated Anti-Epidermal Growth Factor Receptor Monoclonal Antibody 134-mG 2a-f Exerts Antitumor Activities in Mouse Xenograft Models of Dog Epidermal Growth Factor Receptor-Overexpressed Cells. Monoclon Antib Immunodiagn Immunother. 2021.08; 40 (4): 177-183. ( PubMed, DOI )

116. Okuyama K, Hayashida S, Rokutanda S, Kawakita A, Soutome S, Sawada S, Yanamoto S, Kojima Y, Umeda M. Surgical strategy for medication-related osteonecrosis of the jaw (MRONJ) on maxilla: A multicenter retrospective study. J Dent Sci. 2021.07; 16 (3): 885-890. ( PubMed, DOI )

117. Tanaka T, Ohishi T, Asano T, Takei J, Nanamiya R, Hosono H, Sano M, Harada H, Kawada M, Kaneko MK, Kato Y. An anti-TROP2 monoclonal antibody TrMab-6 exerts antitumor activity in breast cancer mouse xenograft models. Oncol Rep. 2021.07; 46 (1): 132. ( PubMed, DOI )

118. Fukuda S, Akiyama M, Niki Y, Kawatsura R, Harada H, Nakahama K. Inhibitory effects of miRNAs in astrocytes on C6 glioma progression via connexin 43. Mol Cell Biochem. 2021.07; 476 (7): 2623-2632. ( PubMed, DOI )

119. Shiba T, Watanabe T, Komatsu K, Koyanagi T, Nemoto T, Ohsugi Y, Michi Y, Katagiri S, Takeuchi Y, Ishihara K, Iwata T. Non-surgical treatment for periodontitis and peri-implantitis: longitudinal clinical and bacteriological findings-A case report with a 7-year follow-up evaluation. SAGE Open Med Case Rep. 2021.07; 9 2050313X211029154. ( PubMed, DOI )

120. Tsushima F, Sakurai J, Uesugi A, Oikawa Y, Ohsako T, Mochizuki Y, Hirai H, Kayamori K, Harada H. Malignant transformation of oral lichen planus: a retrospective study of 565 Japanese patients. BMC Oral Health. 2021.06; 21 (1): 298. ( PubMed, DOI )

121. Nanamiya R, Takei J, Asano T, Sano M, Tanaka T, Hosono H, Harada H, Sakai Y, Mizuno T, Suzuki H, Kaneko MK, Kato Y. Ferret Podoplanin is Detected by PMab-241 in Immunohistochemistry. Monoclon Antib Immunodiagn Immunother. 2021.06; 40 (3): 134-140. ( PubMed, DOI )

122. Nanamiya R, Takei J, Asano T, Tanaka T, Sano M, Nakamura T, Yanaka M, Hosono H, Kaneko MK, Kato Y. Development of Anti-Human CC Chemokine Receptor 9 Monoclonal Antibodies for Flow Cytometry Monoclon Antib Immunodiagn Immunother. 2021.06; 40 (3): 101-106. ( PubMed, DOI )

123. Hosono H, Asano T, Takei J, Sano M, Tanaka T, Kaneko MK, Kato Y. Development of an Anti-Elephant Podoplanin Monoclonal Antibody PMab-265 for Flow cytometry. Monoclon Antib Immunodiagn Immunother. 2021.06; 40 (3): 141-145. ( PubMed, DOI )

124. Tanaka T, Asano T, Sano M, Takei J, Hosono H, Nanamiya R, Nakamura T, Yanaka M, Harada H, Fukui M, Suzuki H, Uchida K, Nakagawa T, Kato Y, Kaneko MK. Development of Monoclonal Antibody PMab-269 Against California Sea Lion Podoplanin. Monoclon Antib Immunodiagn Immunother. 2021.06; 40 (3): 124-133. ( PubMed, DOI )

125. Asano A, Nanamiya R, Takei J, Nakamura T, Yanaka M, Hosono H, Tanaka T, Sano M, Kaneko MK, Kato Y. Development of Anti-Mouse CC Chemokine Receptor 3 Monoclonal Antibodies for Flow Cytometry. Monoclon Antib Immunodiagn Immunother. 2021.06; 40 (3): 107-112. ( PubMed, DOI )

126. Oikawa Y, Tanaka K, Ohsako T, Kugimoto T, Kuroshima T, Hirai H, Tomioka H, Shimamoto H, Michi Y, Sakamoto K, Ikeda T, Harada H. Comparison of Clinicopathological Characteristics Between the Anterior and Posterior Type of Squamous Cell Carcinoma of the Floor of the Mouth: The Anterior Type Is a Risk Factor for Multiple Primary Cancer. Front Oncol. 2021.06; 11 682428. ( PubMed, DOI )

127. Sawa Y, Ibaragi S, Okui T, Yamashita J, Ikebe T, Harada H. Expression of SARS-CoV-2 entry factors in human oral tissue. J Anat. 2021.06; 238 (6): 1341-1354. ( PubMed, DOI )

128. Yu Oikawa, Takuma Kugimoto, Yoshihisa Kashima, Kohei Okuyama, Toshimitsu Ohsako, Takeshi Kuroshima, Hideaki Hirai, Hirofumi Tomioka, Hiroaki Shimamoto, Yasuyuki Michi, Hiroyuki Harada. Surgical treatment for oral tongue squamous cell carcinoma: A retrospective study of 432 patients. Glob Health Med. 2021.06; 3 (3): 157-162. ( PubMed, DOI )

129. Oikawa Yu, Kugimoto Takuma, Kashima Yoshihisa, Okuyama Kohei, Ohsako Toshimitsu, Kuroshima Takeshi, Hirai Hideaki, Tomioka Hirofumi, Shimamoto Hiroaki, Michi Yasuyuki, Harada Hiroyuki. 口腔舌扁平上皮癌に対する外科療法　患者432名を対象とした後方視的研究(Surgical treatment for oral tongue squamous cell carcinoma: A retrospective study of 432 patients) Global Health & Medicine. 2021.06; 3 (3): 157-162. ( 医中誌 )

130. Yokokawa M, Hirai H, Tran C. M, Fukuda S, Sakamoto K, Ikeda T, Harada H. Adenoid cystic carcinoma metastas E12:T13 ized from the maxilla to the mandible:A case report. J Oral Mxillofac Surg Med Pathol. 2021.05; 33 (3): 371-375. ( DOI )

131. Yokokawa Misaki, Hirai Hideaki, Tran Cuong Minh, Fukuda Shuhei, Sakamoto Kei, Ikeda Tohru, Harada Hiroyuki. 上顎から下顎へと転移した腺様嚢胞癌　症例報告(Adenoid cystic carcinoma metastasized from the maxilla to the mandible: A case report) Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology. 2021.05; 33 (3): 371-375. ( 医中誌 )

132. Yamada I, Yohino N, Yokokawa M, Oikawa Y, Harada H, Hikishima K, Kurabayashi T, Saida Y, Tateishi U, Ohata Y. Diffusion tensor imaging of oral carcinoma: Clinical evaluation and comparison with histopathological findings. Magn Reson Imaging. 2021.04; 77 99-108. ( PubMed, DOI )

133. Tran CM, Kuroshima T, Oikawa Y, Michi Y, Kayamori K, Harada H. Clinicopathological and immunohistochemical characteristics of pigmented oral squamous cell carcinoma. Oncol Lett. 2021.04; 21 (4): 339. ( PubMed, DOI )

134. Tanaka T, Nanamiya R, Takei J, Nakamura T, Yanaka M, Hosono H, Sano M, Asano T, Kaneko MK, Kato Y. Development of Anti-Mouse CC chemokine receptor 8 Monoclonal Antibodies for Flow Cytometry. Monoclon Antib Immunodiagn Immunother. 2021.04; 40 (2): 65-70. ( PubMed, DOI )

135. Takei J, Asano T, Nanamiya R, Nakamura T, Yanaka M, Hosono H, Tanaka T, Sano M, Kaneko MK, Harada H, Kato Y. Development of Anti-Human T-Cell Immunoreceptor with Ig and ITIM Domains (TIGIT) Monoclonal Antibodies for Flow Cytometry. Monoclon Antib Immunodiagn Immunother. 2021.04; 40 (2): 71-75. ( PubMed, DOI )

136. Suga T, Tu TTH, Takenoshita M, Mikuzuki L, Umezaki Y, Shimamoto H, Michi Y, Hong C, Abiko Y, Ikeda T, Uzawa N, Harada H, Toyofuku A. Case Report: Hidden Oral Squamous Cell Carcinoma in Oral Somatic Symptom Disorder. Front Psychiatry. 2021.04; 12 651871. ( PubMed, DOI )

137. Ota Y, Noguchi T, Ariji E, Fushimi C, Fuwa N, Harada H, Hayashi T, Hayashi R, Honma Y, Miura M, Mori T, Nagatsuka H, Okura M, Ueda M, Uzawa N, Yagihara K, Yagishita H, Yamashiro M, Yanamoto S, Kirita T. General rules for clinical and pathological studies on oral cancer (2nd edition): a synopsis. Int J Clin Oncol. 2021.04; 26 (4): 623-635. ( PubMed, DOI )

138. Ota Yoshihide, Noguchi Tadahide, Ariji Eiichiro, Fushimi Chihiro, Fuwa Nobukazu, Harada Hiroyuki, Hayashi Takafumi, Hayashi Ryuichi, Honma Yoshitaka, Miura Masahiko, Mori Taisuke, Nagatsuka Hitoshi, Okura Masaya, Ueda Michihiro, Uzawa Narikazu, Yagihara Kazuhiro, Yagishita Hisao, Yamashiro Masashi, Yanamoto Souichi, Kirita Tadaaki, Scientific Committee on General Rules for Clinical,Pathological Studies of Oral Cancer,Japanese Society of Oral Oncology. 口腔癌取扱い規約(第2版)　概要(General rules for clinical and pathological studies on oral cancer(2nd edition): a synopsis) International Journal of Clinical Oncology. 2021.04; 26 (4): 623-635. ( 医中誌 )

139. Tomioka H, Yamagata Y, Oikawa Y, Ohsako T, Kugimoto T, Kuroshima T, Hirai H, Shimamoto H, Harada H. Risk factors for distant metastasis in locoregionally controlled oral squamous cell carcinoma: a retrospective study. Sci Rep. 2021.03; 11 (1): 5213. ( PubMed, DOI )

140. Sayama Y, Kaneko MK, Takei J, Hosono H, Sano M, Asano T, Kato Y. Establishment of a novel anti-TROP2 monoclonal antibody TrMab-29 for immunohistochemical analysis. Biochem Biophys Rep. 2021.03; 25 100902. ( PubMed, DOI )

141. Okuyama K, Naruse T, Yanamoto S, Hayashida S, Rokutanda S, Kawakita A, Furukawa K, Umeda M. Prodromal symptoms of streptococcal toxic shock syndrome caused by Group A Streptococcus in the head and neck region: a case report. J Oral Maxillofac Surg Med Pathol. 2021.03; 33 (2): 211-214. ( DOI )

142. Okuyama K, Suzuki K, Naruse T, Tsuchihashi H, Yanamoto S, Kaida A, Miura M, Umeda M, Yamashita S. Prolonged cetuximab treatment promotes p27Kip1-mediated G1 arrest and autophagy in head and neck squamous cell carcinoma. Sci Rep. 2021.03; 11 5259. ( PubMed, DOI )

143. Fukawa Y, Sakamoto K, Kugimoto T, Michi Y, Harada H, Yamamoto M, Kitagawa M, Ikeda T, Yamamoto K. Nodular lymphocyte-predominant Hodgkin lymphoma involving the hard palate. Pathol Int. 2021.03; 71 (3): 213-215. ( PubMed, DOI )

144. Fukawa Yuki, Sakamoto Kei, Kugimoto Takuma, Michi Yasuyuki, Harada Hiroyuki, Yamamoto Masahide, Kitagawa Masanobu, Ikeda Tohru, Yamamoto Kouhei. 硬口蓋に発症した結節性リンパ球優位型Hodgkinリンパ腫(Nodular lymphocyte-predominant Hodgkin lymphoma involving the hard palate) Pathology International. 2021.03; 71 (3): 213-215. ( 医中誌 )

145. Nishii N, Hirotsu Y, Koida N, Takahashi Y, Takagawa Y, Amemiya K, Oyama T, Mochizuki H, Furusawa-Nishii E, Harada H, Omata M. Discrepancy Between Clinical Diagnosis and Whole-exome Sequencing-based Clonality Analysis of Synchronous Multiple Oral Cancers. Anticancer Res. 2021.02; 41 (2): 1035-1040. ( PubMed, DOI )

146. Baba S, Akashi T, Kayamori K, Ohuchi T, Ogawa I, Kubota N, Nakano K, Nagatsuka H, Hasegawa H, Matsuzaka K, Tomii S, Uchida K, Katsuta N, Sekiya T, Ando N, Miura K, Ishibashi H, Ariizumi Y, Asakage T, Michi Y, Harada H, Sakamoto K, Eishi Y, Okubo K, Ikeda T. Homeobox transcription factor engrailed homeobox 1 is a possible diagnostic marker for adenoid cystic carcinoma and polymorphous adenocarcinoma. Pathol Int. 2021.02; 71 (2): 113-123. ( PubMed, DOI )

147. Baba Shunichi, Akashi Takumi, Kayamori Kou, Ohuchi Tomoyuki, Ogawa Ikuko, Kubota Nobuhisa, Nakano Keisuke, Nagatsuka Hitoshi, Hasegawa Hiromasa, Matsuzaka Kenichi, Tomii Shohei, Uchida Keisuke, Katsuta Noriko, Sekiya Takahiro, Ando Noboru, Miura Keiko, Ishibashi Hironori, Ariizumi Yousuke, Asakage Takahiro, Michi Yasuyuki, Harada Hiroyuki, Sakamoto Kei, Eishi Yoshinobu, Okubo Kenichi, Ikeda Tohru. ホメオボックス転写因子engrailed homeobox 1は腺様嚢胞癌および多形腺癌の診断マーカーの可能性がある(Homeobox transcription factor engrailed homeobox 1 is a possible diagnostic marker for adenoid cystic carcinoma and polymorphous adenocarcinoma) Pathology International. 2021.02; 71 (2): 113-123. ( 医中誌 )

148. Terauchi M, Michi Y, Hirai H, Sugiyama K, Wada A, Harada H, Yoda T. Prognostic factors in mucoepidermoid carcinoma of the minor salivary glands: A single-center retrospective study. Oral Surg Oral Med Oral Pathol Oral Radiol. 2021.01; 131 (2): 209-216. ( PubMed, DOI )

149. Sakakitani S, Podyma-Inoue KA, Takayama R, Takahashi K, Ishigami-Yuasa M, Kagechika H, Harada H, Watabe T. Activation of β2-adrenergic receptor signals suppresses mesenchymal phenotypes of oral squamous cell carcinoma cells. Cancer Sci. 2021.01; 112 (1): 155-167. ( PubMed, DOI )

150. Sakakitani Shintaro, Podyma-Inoue Katarzyna A., Takayama Rina, Takahashi Kazuki, Ishigami-Yuasa Mari, Kagechika Hiroyuki, Harada Hiroyuki, Watabe Tetsuro. β2-アドレナリン受容体シグナルの活性化は口腔扁平上皮癌細胞の間葉系表現型を抑制する(Activation of β2-adrenergic receptor signals suppresses mesenchymal phenotypes of oral squamous cell carcinoma cells) Cancer Science. 2021.01; 112 (1): 155-167. ( 医中誌 )

151. Nishii N, Shimamoto H, Ohsako T, Yokokawa M, Sato Y, Ohata Y, Kayamori K, Ikeda T, Harada H. Renal cell carcinoma metastasis to the maxillary bone successfully treated with surgery after vascular embolization: a case report J Med Case Rep. 2020.12; 14 (1): 193. ( PubMed, DOI )

152. Hosono H, Ohishi T, Takei J, Asano T, Sayama Y, Kawada M, Kaneko MK, Kato Y. The anti-epithelial cell adhesion molecule (EpCAM) monoclonal antibody EpMab-16 exerts antitumor activity in a mouse model of colorectal adenocarcinoma Oncol Lett. 2020.12; 20 (6): 383. ( PubMed, DOI )

153. Kaneko MK, Ohishi T, Takei J, Sano M, Nakamura T, Hosono H, Yanaka M, Asano T, Sayama Y, Harada H, Kawada M, Kato Y. The Anti-EpCAM monoclonal antibody (EpMab-16) exerts anti-tumor activity against oral squamous cell carcinomas Oncol Rep. 2020.12; 44 (6): 2517-2526. ( PubMed, DOI )

154. Shimono H, Kaida A, Homma H, Nojima H, Onozato Y, Harada H, Miura M. Fluctuation in radioresponse of HeLa cells during the cell cycle evaluated based on micronucleus frequency Sci Rep. 2020.11; 10 (1): 20873 (Open access). ( PubMed, DOI )

155. Nishimura T, Nakamura Y, Kinoshita N, Yamamoto K, Sasaki Y, Akiyoshi K. Biocatalytic Hybrid Films Self-Assembled from Carbohydrate Block Copolymers and Polysaccharides for Enzyme Prodrug Therapy ACS Appl Bio Mater. 2020.11; 3 (12): 8865-8871. ( DOI )

156. Uesugi A, Tsushima F, Kodama M, Kuroshima T, Sakurai J, Harada H. Oral granuloma in a pediatric patient with chronic graft-versus-host disease: A case report World J Clin Cases. 2020.11; 8 (22): 5663-5669. ( PubMed, DOI )

157. Takei J, Kaneko MK, Ohishi T, Hosono H, Nakamura T, Yanaka M, Sano M, Asano T, Sayama Y, Kawada M, Harada H, Kato Y. A defucosylated anti-CD44 monoclonal antibody 5-mG2a-f exerts antitumor effects in mouse xenograft models of oral squamous cell carcinoma Oncol Rep. 2020.11; 44 (5): 1949-1960. ( PubMed, DOI )

158. Hosono H, Takei J, Ohishi T, Sano M, Asano T, Sayama Y, Nakamura T, Yanaka M, Kawada M, Harada H, Kaneko MK, Kato Y. Anti-EGFR monoclonal antibody 134-mG2a exerts antitumor effects in mouse xenograft models of oral squamous cell carcinoma Int J Mol Med. 2020.10; 46 (4): 1443-1452. ( PubMed, DOI )

159. Kaneko MK, Ohishi T, Nakamura T, Inoue H, Takei J, Sano M, Asano T, Sayama Y, Hosono H, Suzuki H, Kawada M, Kato Y. Development of Core-Fucose-Deficient Humanized and Chimeric Anti-Human Podoplanin Antibodies Monoclon Antib Immunodiagn Immunother. 2020.10; 39 (5): 167-174. ( PubMed, DOI )

160. Kayamori K, Tsuchiya M, Michi Y, Kuribayashi A, Mikami T, Sakamoto K, Yoda T, Ikeda T. Primordial odontogenic tumor occurred in the maxilla with unique calcifications and its crucial points for differential diagnosis Pathol Int. 2020.10; 71 (1): 80-87. ( PubMed, DOI )

161. Tsuchihashi H, Naruse T, Yanamoto S, Okuyama K, Furukawa K, Omori K, Umeda M. Selective inhibition of PI3K110α as a novel therapeutic strategy for cetuximab-resistant oral squamous cell carcinoma. Oncol Rep. 2020.09; 44 (3): 863-872. ( PubMed, DOI )

162. Hirai H, Ohsako T, Kugimoto T, Tomioka H, Michi Y, Kayamori K, Yoda T, Miura M, Yoshimura R, Harada H. Comparison of 50- and 66-Gy total irradiation doses for postoperative cervical treatment of patients with oral squamous cell carcinoma Oral Oncol. 2020.08; 107 104708. ( PubMed, DOI )

163. Asano T, Sano M, Takei J, Sayama Y, Kaneko MK, Kato Y. Epitope mapping of the anti-diacylglycerol kinase monoclonal antibody DhMab-4 for immunohistochemical analysis Monoclon Antib Immunodiagn Immunother. 2020.08; 39 (4): 117-122. ( PubMed, DOI )

164. Shibata E, Morita KI, Kayamori K, Maruiwa M, Michi Y, Sato Y, Takeuchi K, Ikeda T, Harada H, Yoda T. Secretory carcinoma around Stensen's duct misdiagnosed as salivary duct cyst Int J Clin Exp Pathol. 2020.08; 13 (8): 2211-2217. ( PubMed )

165. Kato Y, Ohishi T, Takei J, Nakamura T, Sano M, Asano T, Sayama Y, Hosono H, Kawada M, Kaneko MK. An Anti-Human Epidermal Growth Factor Receptor 2 Monoclonal Antibody H 2 Mab-19 Exerts Antitumor Activity in Mouse Colon Cancer Xenografts Monoclon Antib Immunodiagn Immunother. 2020.08; 39 (4): 123-128. ( PubMed, DOI )

166. Takei J, Ohishi T, Kaneko MK, Harada H, Kawada M, Kato Y. A defucosylated anti-PD-L1 monoclonal antibody 13-mG 2a-f exerts antitumor effects in mouse xenograft models of oral squamous cell carcinoma Biochem Biophys Rep. 2020.08; 30 (24): 100801. ( PubMed, DOI )

167. Kaneko MK, Sano M, Takei J, Asano T, Sayama Y, Hosono H, Kobayashi A, Konnai S, Kato Y. Development and Characterization of Anti-Sheep Podoplanin Monoclonal Antibodies PMab-253 and PMab-260 Monoclon Antib Immunodiagn Immunother. 2020.08; 39 (4): 144-145. ( PubMed, DOI )

168. Kato Y, Ohishi T, Takei J, Nakamura T, Kawada M, Kaneko MK. An Antihuman Epidermal Growth Factor Receptor 2 Monoclonal Antibody (H2Mab-19) Exerts Antitumor Activity in Glioblastoma Xenograft Models Monoclon Antib Immunodiagn Immunother. 2020.08; 39 (4): 135-139. ( PubMed, DOI )

169. Kinoshita N, Sasaki Y, Marukawa E, Hirose R, Sawada SI, Harada H, Akiyoshi K. Crosslinked nanogel-based porous hydrogel as a functional scaffold for tongue muscle regeneration J Biomater Sci Polym Ed. 2020.07; 31 (10): 1254-1271. ( PubMed, DOI )

170. Yamada SI, Hasegawa T, Okuyama K, Yamakawa N, Okura M, Hashidume M, Yanamoto S, Akashi M, Kirita T, Umeda M, Kurita H. Clinical significance of the G8 screening tool in elderly patients with oral squamous cell carcinoma Clin Oral Investig. 2020.06; 24 (6): 1953-1961. ( PubMed, DOI )

171. Kato Y, Ohishi T, Sano M, Asano T, Sayama Y, Takei J, Kawada M, Kaneko MK. H2Mab-19 Anti-Human Epidermal Growth Factor Receptor 2 Monoclonal Antibody Therapy Exerts Antitumor Activity in Pancreatic Cancer Xenograft Models Monoclon Antib Immunodiagn Immunother. 2020.06; 39 (3): 61-65. ( PubMed, DOI )

172. Kato Y, Takei J, Sano M, Asano T, Sayama Y, Uchida K, Nakagawa T, Kaneko MK. Detection of lion podoplanin using the anti-tiger podoplanin monoclonal antibody PMab-231 Monoclon Antib Immunodiagn Immunother. 2020.06; 39 (3): 91-94. ( PubMed, DOI )

173. Kato Y, Furusawa Y, Sano M, Takei J, Nakamura T, Yanaka M, Okamoto S, Handa S, Komatsu Y, Asano T, Sayama Y, Kaneko MK. Development of an Anti-Sheep Podoplanin Monoclonal Antibody PMab-256 for Immunohistochemical Analysis of Lymphatic Endothelial Cells Monoclon Antib Immunodiagn Immunother. 2020.06; 39 (3): 82-90. ( PubMed, DOI )

174. Sayama Y, Sano M, Asano T, Furusawa Y, Takei J, Nakamura T, Yanaka M, Okamoto S, Handa S, Komatsu Y, Nakamura Y, Yanagawa M, Kaneko MK, Kato Y. Epitope mapping of PMab-241, a lymphatic endothelial cell-specific anti-bear podoplanin monoclonal antibody Monoclon Antib Immunodiagn Immunother. 2020.06; 39 (3): 77-81. ( PubMed, DOI )

175. Takagawa Y , Gen Y, Muramatsu T, Tanimoto K, Inoue J, Harada H, Inazawa J . miR-1293, a Candidate for miRNA-Based Cancer Therapeutics, Simultaneously Targets BRD4 and the DNA Repair Pathway Mol ther. 2020.06; 28 (6): 1494-1505. ( PubMed, DOI )

176. Uesugi A, Mochida K, Harada H, Imai H. Ossifying fibroma arising from the zygomatic arch: A case report. Journal of stomatology, oral and maxillofacial surgery. 2020.06; 121 (3): 288-291. ( PubMed, DOI )

177. Kaneko A, Marukawa E, Harada H. Hydroxyapatite Nanoparticles as Injectable Bone Substitute Material in a Vertical Bone Augmentation Model In Vivo. 2020.05; 34 (3): 1053-1061.

178. Kashima Y, Nishii N, Tachinami H, Furusawa E, Nagai S, Harada H, Azuma M. Orthotopic tongue squamous cell carcinoma (SCC) model exhibiting a different tumor-infiltrating T-cell status with margin-restricted CD8+ T cells and regulatory T cell-dominance, compared to skin SCC. Biochem Biophys Res Commun. 2020.05; 526 (1): 218-224. ( PubMed, DOI )

179. Shimamoto H, Hirota Y, Kashima Y, Kinoshita N, Yokokawa M, Ikeda T, Harada H. Granulocyte colony-stimulating factor-producing squamous cell carcinoma of the tongue exhibiting characteristic fluorine-18 deoxyglucose accumulation on positron emission tomography–computed tomography: A case report World J Clin Case. 2020.05; 8 (9): 1666-1673. ( PubMed, DOI )

180. Naruse T, Yanamoto S, Okuyama K, Ohmori K, Tsuchihashi H, Furukawa K, Yamada SI, Umeda M. Immunohistochemical Study of PD-1/PD-L1 Axis Expression in Oral Tongue Squamous Cell Carcinomas: Effect of Neoadjuvant Chemotherapy on Local Recurrence Pathol Oncol Res. 2020.04; 26 (2): 735-742. ( DOI )

181. Takei J, Kaneko MK, Ohishi T, Kawada M, Harada H, Kato Y. H2Mab-19, an anti-human epidermal growth factor receptor 2 monoclonal antibody exerts antitumor activity in mouse oral cancer xenografts Exp Ther Med. 2020.04; 20 (2): 846-853. ( PubMed, DOI )

182. Kato Y, Ito Y, Ohishi T, Kawada M, Nakamura T, Sayama Y, Sano M, Asano T, Yanaka M, Okamoto S, Handa S, Komatsu Y, Takei J, Kaneko MK. Antibody–drug conjugates using mouse–canine chimeric anti-dog podoplanin antibody exerts antitumor activity in a mouse xenograft model Monoclon Antib Immunodiagn Immunother. 2020.04; 39 (2): 37-44. ( PubMed, DOI )

183. Yamada S, Kaneko MK, Sayama Y, Asano T, Sano M, Yanaka M, Nakamura T, Okamoto S, Handa S, Komatsu Y, Nakamura Y, Furusawa Y, Takei J, Kato Y. Development of novel mouse monoclonal antibodies against human CD19 Monoclon Antib Immunodiagn Immunother. 2020.04; 39 (2): 45-50. ( PubMed, DOI )

184. Takei J, Kaneko MK, Ohishi T, Kawada M, Harada H, Kato Y. A novel anti-EGFR monoclonal antibody (EMab-17) exerts antitumor activity against oral squamous cell carcinomas via antibody-dependent cellular cytotoxicity and complement-dependent cytotoxicity Oncol Lett. 2020.04; 19 (4): 2809-2816. ( PubMed, DOI )

185. Ohsako T, Shimamoto H, Tomioka H, Hirai H, Kuroshima T, Mochizuki Y, Kugimoto T, Tsushima F, Nakamura S, Kurabayashi T, Harada H. Detection of extraoral primary cancers by positron emission tomography/computed tomography in patients with oral squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol. 2020.03; 129 (3): 272-276. ( PubMed, DOI )

186. Yokokawa M, Morita KI, Oikawa Y, Kayamori K, Sakamoto K, Ikeda T, Harada H. Co‐expression of EGFR and MET has a synergistic effect on the prognosis of patients with oral squamous cell carcinoma J Oral Pathol Med. 2020.03; 49 (3): 235-242. ( PubMed, DOI )

187. Yahara H, Horita S, Yanamoto S, Kitagawa Y, Asaka T, Yoda T, Morita K, Michi Y, Takechi M, Shimasue H, Maruoka Y, Kondo E, Kusukawa J, Tsujiguchi H, Sato T, Kannon T, Nakamura H, Tajima A, Hosomichi K, Yahara K. A Targeted Genetic Association Study of the Rare Type of Osteomyelitis J Dent Res. 2020.03; 99 (3): 271-276. ( PubMed, DOI )

188. Yamamoto D, Kayamori K, Sakamoto K, Tsuchiya M, Ikeda T, Harada H, Yoda T, Watabe T, Hara-Yokoyama M. Intracellular claudin-1 at the invasive front of tongue squamous cell carcinoma is associated with lymph node metastasis Cancer Sci. 2020.02; 111 (2): 700-712. ( PubMed, DOI )

189. Nguyen CTK, Sawangarun W, Mandasari K, Morita KI, Harada H, Kayamori K, Yamaguchi A, Sakamoto K. AIRE is induced in oral squamous cell carcinoma and promotes cancer gene expression PLoS ONE. 2020.02; 15 (2): e0222689. ( PubMed, DOI )

190. Yukimori A, Tsuchiya M, Wada A, Michi Y, Kayamori K, Sakamoto K, Ikeda T. Genetic and histopathological analysis of a case of primary intraosseous carcinoma, NOS with features of both ameloblastic carcinoma and squamous cell carcinoma World J Surg Oncol. 2020.02; 18 (1): 45. ( PubMed, DOI )

191. Yamamoto Daisuke, Kayamori Kou, Sakamoto Kei, Tsuchiya Maiko, Ikeda Tohru, Harada Hiroyuki, Yoda Tetsuya, Watabe Tetsuro, Hara-Yokoyama Miki. 舌扁平上皮癌の浸潤先端部にみられる細胞内のクローディン1はリンパ節転移と関連している(Intracellular claudin-1 at the invasive front of tongue squamous cell carcinoma is associated with lymph node metastasis) Cancer Science. 2020.02; 111 (2): 700-712. ( 医中誌 )

192. Nojima H, Homma H, Onozato Y, Kaida A, Harada H, Miura M. Differential properties of mitosis-associated events following CHK1 and WEE1 inhibitor treatments in human tongue carcinoma cells Exp Cell Res. 2020.01; 388 (2): 111720. ( PubMed, DOI )

193. Kagifuku Y, Tohara H, Wakasugi Y, Susa C, Nakane A, Toyoshima M, Nakakuki K, Kabasawa Y, Harada H, Minakuchi S. What Factors Affect Changes in Body Composition and Swallowing Function in Patients Hospitalized for Oral Cancer Surgery? Clin Interv Aging. 2020.01; 15 1-7. ( PubMed, DOI )

194. Homma H, Nojima H, Kaida A, Miura M. Induction of endomitosis-like event in HeLa cells following CHK1 inhibitor treatment Biochem Biophys Res Commun. . 2019.12;

195. Oikawa Y, Michi Y, Tsushima F, Tomioka H, Mochizuki Y, Kugimoto T, Osako T, Nojima H, Yokokawa M, Kashima Y, Harada H. Management of retropharyngeal lymph node metastasis in oral cancer. Oral Oncology. 2019.12; 99 104471. ( PubMed, DOI )

196. Kato Y, Takei J, Furusawa Y, Sayama Y, Sano M, Konnai S, Kobayashi A, Harada H, Takahashi M, Suzuki H, Yamada S, Kaneko MK. Epitope Mapping of Anti-Bear Podoplanin Monoclonal Antibody PMab-247. Monoclonal antibodies in immunodiagnosis and immunotherapy. 2019.10; 38 (5): 230-233. ( PubMed, DOI )

197. Takei J, Itai S, Harada H, Furusawa Y, Miwa T, Fukui M, Nakamura T, Sano M, Sayama Y, Yanaka M, Handa S, Hisamatsu K, Nakamura Y, Yamada S, Kaneko MK, Kato Y. Characterization of Anti-Goat Podoplanin Monoclonal Antibody PMab-235 Using Immunohistochemistry Against Goat Tissues. Monoclonal antibodies in immunodiagnosis and immunotherapy. 2019.10; 38 (5): 213-219. ( PubMed, DOI )

198. Kojima Y, Kawaoka Y, Sawada S, Hayashida S, Okuyama K, Yutori H, Kawakita A, Ishida S, Soutome S, Yanamoto S, Umeda M, Iwai H.. Clinical significance of periosteal reaction as a predictive factor for treatment outcome of medication-related osteonecrosis of the jaw. Journal of Bone and Mineral Metabolism. 2019.09; 37 (5): 913-919. ( PubMed, DOI )

199. Nakazato K, Mogushi K, Kayamori K, Tsuchiya M, Takahashi KI, Sumino J, Michi Y, Yoda T, Uzawa N. Glucose metabolism changes during the development and progression of oral tongue squamous cell carcinomas. Oncol Lett. 2019.08; 8 (2): 1372-1380.

200. Takei J, Furusawa Y, Yamada S, Nakamura T, Sayama Y, Sano M, Konnai S, Kobayashi A, Harada H, Kaneko MK, Kato Y. PMab-247 Detects Bear Podoplanin in Immunohistochemical Analysis. Monoclon Antib Immunodiagn Immunother.. 2019.08; 38 (4): 171-174.

201. Okuyama K, Naruse T, Yutori H, Yanamoto S, Umeda M.. Oral surgery in patients with antiphospholipid syndrome. Journal of Oral Science. 2019.08; 61 (3): 386-390. ( PubMed, DOI )

202. Xia Y, Ohno T, Nishii N, Bhingare A, Tachinami H, Kashima Y, Nagai S, Saito H, Nakae S, Azuma M. Endogenous IL-33 exerts CD8+ T cell antitumor responses overcoming pro-tumor effects by regulatory T cells in a colon carcinoma model Biochemical and Biophysical Research Communications. 2019.08; 518 (2): 331-336. ( PubMed, DOI )

203. Kato Y, Ohishi T, Yamada S, Itai S, Takei J, Sano M, Nakamura T, Harada H, Kawada M, Kaneko MK.. Anti-Human Epidermal Growth Factor Receptor 2 Monoclonal Antibody H2Mab-41-Exerts Antitumor Activity in a Mouse Xenograft Model of Colon Cancer Monoclon. Antib. Immunodiagn. Immunother.. 2019.08; 38 (4): 157-161.

204. Atsushi Uesugi, Kaori Mochida, Hiroyuki Harada, Hideki Imai. Ossifying fibroma arising from the zygomatic arch: a case report Journal of Stomatology Oral and Maxillofacial Surgery. 2019.08;

205. Takei J, Furusawa Y, Yamada S, Nakamura T, Sayama Y, Sano M, Konnai S, Kobayashi A, Harada H, Kaneko MK, Kato Y. PMab-247 Detects Bear Podoplanin in Immunohistochemical Analysis. Monoclonal antibodies in immunodiagnosis and immunotherapy. 2019.08; 38 (4): 171-174. ( PubMed, DOI )

206. Kato Y, Ohishi T, Yamada S, Itai S, Takei J, Sano M, Nakamura T, Harada H, Kawada M, Kaneko MK. Anti-Human Epidermal Growth Factor Receptor 2 Monoclonal Antibody H(2)Mab-41 Exerts Antitumor Activity in a Mouse Xenograft Model of Colon Cancer. Monoclonal antibodies in immunodiagnosis and immunotherapy. 2019.08; 38 (4): 157-161. ( PubMed, DOI )

207. Komiya R, Wada T, Tsushima F, Sakamoto K, Ikeda T, Yamaguchi A, Harada H, Uo M. Quantitation and distribution of metallic elements in sequestra of medication-related osteonecrosis of jaw (MRONJ) using inductively coupled plasma atomic emission spectroscopy and synchrotron radiation X-ray fluorescence analysis Journal pb Bone and Mineral Metabolism. 2019.07; 37 (4): 676-684.

208. Yoshikazu F, Shinji Y, Takuro N, Masato S, Yusuke S, Shunsuke I,. A monoclonal antibody for the immunohistochemical analysis of goat podoplanin Heliyon. 2019.07; 5 (7): e02063.

209. Komiya Ruri, Wada Takahiro, Tsushima Fumihiko, Sakamoto Kei, Ikeda Tohru, Yamagchi Akira, Harada Hiroyuki, Uo Motohiro. 誘導結合プラズマ原子発光分光法とシンクロトロン放射光X線蛍光解析を用いた薬剤関連性顎骨壊死(MRONJ)の腐骨における金属元素の定量と分布(Quantitation and distribution of metallic elements in sequestra of medication-related osteonecrosis of jaw(MRONJ) using inductively coupled plasma atomic emission spectroscopy and synchrotron radiation X-ray fluorescence analysis) Journal of Bone and Mineral Metabolism. 2019.07; 37 (4): 676-684. ( 医中誌 )

210. Furusawa Y, Yamada S, Itai S, Nakamura T, Takei J, Sano M, Harada H, Fukui M, Kaneko MK, Kato Y. Establishment of a monoclonal antibody PMab-233 for immunohistochemical analysis against Tasmanian devil podoplanin. Biochemistry and biophysics reports. 2019.07; 18 100631. ( PubMed, DOI )

211. Furusawa Y, Yamada S, Itai S, Nakamura T, Yanaka M, Sano M, Harada H, Fukui M, Kaneko MK, Kato Y. PMab-219: A monoclonal antibody for the immunohistochemical analysis of horse podoplanin. Biochemistry and biophysics reports. 2019.07; 18 100616. ( PubMed, DOI )

212. Kato Y, Furusawa Y, Itai S, Takei J, Nakamura T, Sano M, Harada H, Yamada S, Kaneko MK. . Establishment of an Anticetacean Podoplanin Monoclonal Antibody PMab-237 for Immunohistochemical Analysis. Monoclon Antib Immunodiagn Immunother.. 2019.06; 38 (3): 108-113.

213. Takei J, Itai S, Furusawa Y, Yamada S, Nakamura T, Sano M, Harada H, Fukui M, Kaneko MK, Kato Y. Epitope mapping of anti-tiger podoplanin monoclonal antibody PMab-231. Monoclon Antib Immunodiagn Immunother.. 2019.06; 38 (3): 129-132.

214. Kato Y, Furusawa Y, Itai S, Takei J, Nakamura T, Sano M, Harada H, Yamada S, Kaneko MK. Establishment of an Anticetacean Podoplanin Monoclonal Antibody PMab-237 for Immunohistochemical Analysis. Monoclonal antibodies in immunodiagnosis and immunotherapy. 2019.06; 38 (3): 108-113. ( PubMed, DOI )

215. Takei J, Itai S, Furusawa Y, Yamada S, Nakamura T, Sano M, Harada H, Fukui M, Kaneko MK, Kato Y. Epitope Mapping of Anti-Tiger Podoplanin Monoclonal Antibody PMab-231. Monoclonal antibodies in immunodiagnosis and immunotherapy. 2019.06; 38 (3): 129-132. ( PubMed, DOI )

216. Suzuki N, Kuribayashi A, Sakamoto K, Sakamoto J, Nakamura S, Watanabe H, Harada H, Kurabayashi T. Diagnostic abilities of 3T MRI for assessing mandibular invasion of squamous cell carcinoma in the oral cavity: comparison with 64-row multidetector CT. Dento maxillo facial radiology. 2019.05; 48 (4): 20180311. ( PubMed, DOI )

217. Mochizuki Y., Harada H., Oyama J., Sakamoto K., Michi Y., Kuroshima T., Kugimoto T.. Metastatic gastric adenocarcinoma of the tongue with initial symptoms of glossodynia. Curr Probl Cancer. . 2019.05; 2019 May 23. pii: S0147-0272(18)30403-3.

218. Minegishi Saki, Ohtani Susumu, Noritake Kanako, Funakoshi Takeshi, Ishii Namiko, Utsuno Hajime, Sakuma Ayaka, Saitoh Hisako, Yamaguchi Satoshi, Marukawa Eriko, Harada Hiroyuki, Uemura Koichi, Sakurada Koichi. 加熱により増加させたアスパラギン酸ラセミ化率に基づく年齢推定を目的とした象牙質標準試料の調製(Preparation of dentin standard samples for age estimation based on increased aspartic acid racemization rate by heating) Legal Medicine. 2019.05; 38 25-31. ( 医中誌 )

219. Higuchi Y, Tsushima F, Sumikura K, Sato Y, Harada H, Kayamori K, Ikeda T.. Diagnosis and treatment of oral focal mucinosis: a case series. Journal of Medical Case Reports. 2019.04; 13(1) (108): Published online. ( DOI )

220. Furusawa Y, Kaneko MK, Nakamura T, Itai S, Fukui M, Harada H, Yamada S, Kato Y. Establishment of a monoclonal antibody PMab-231 for tiger podoplanin. Monoclon Antib Immunodiagn Immunother.. 2019.04; 38 (2): 89-95.

221. Kaneko MK, Furusawa Y, Sano M, Itai S, Takei J, Harada H, Fukui M, Yamada S, Kato Y. Epitope mapping of the anti-horse podoplanin monoclonal antibody PMab-202. Monoclon Antib Immunodiagn Immunother.. 2019.04; 37 (5): 233-237.

222. Furusawa Y, Yamada S, Itai S, Nakamura T, Takei J, Sano M, Harada H, Fukui M, Kaneko MK, Kato Y. Establishment of a monoclonal antibody PMab-233 for immunohistochemical analysis against Tasmanian devil podoplanin. Biochem Biophys Rep. 2019.04;

223. Tomioka H, Mochizuki Y, Ohsako T, Hirai H, Shimamoto H, Harada H.. Buccinator and Mandibular Node Metastases in Oral Squamous Cell Carcinoma. Journal of oral and maxillofacial surgery. 2019.04; 77 (4): 867-873. ( PubMed, DOI )

224. Tachinami H, Nishii N, Xia Y, Kashima Y, Ohno T, Nagai S, Li L, Tomihara K, Noguchi M, Azuma M. Differences of tumor-recruiting myeloid cells in murine squamous cell carcinoma influence the efficacy of immunotherapy combined with a TLR7 agonist and PD-L1 blockade. Oral Oncology. 2019.04; 91 21-28. ( PubMed, DOI )

225. Okuyama K, Fukushima H, Naruse T, Yanamoto S, Tsuchihashi H, Umeda M.. CD44 Variant 6 Expression and Tumor Budding in the Medullary Invasion Front of Mandibular Gingival Squamous Cell Carcinoma Are Predictive Factors for Cervical Lymph Node Metastasis. Pathology and Oncology Research. 2019.04; 25 (2): 603-609. ( PubMed, DOI )

226. Tomioka H, Mochizuki Y, Ohsako T, Hirai H, Shimamoto H, Harada H.. Buccinator and Mandibular Node Metastases in Oral Squamous Cell Carcinoma Journal of oral and maxillofacial surgery. 2019.04; 77 (4): 867-873. ( DOI )

227. Kishimoto Yo, Harada Hiroyuki, Funakoshi Makiko, Miyamoto Shin-ichi, Suehiro Atsushi, Kitamura Morimasa, Muto Manabu, Tateya Ichiro, Omori Koichi. 高齢患者に対する内視鏡下咽喉頭手術(Endoscopic laryngo-pharyngeal surgery for elderly patients) Auris・Nasus・Larynx. 2019.04; 46 (2): 279-284. ( 医中誌 )

228. Yamada S, Kaneko MK, Furusawa Y, Itai S, Sano M, Nakamura T, Yanaka M, Handa S, Hisamatsu K, Nakamura Y, Koyanagi M, Fukui M, Harada H, Kato Y. Anti-Bovine Podoplanin Monoclonal Antibody PMab-44 Detects Goat Podoplanin in Immunohistochemistry. Monoclonal antibodies in immunodiagnosis and immunotherapy. 2019.04; 38 (2): 96-99. ( PubMed, DOI )

229. Kaneko MK, Furusawa Y, Sano M, Itai S, Takei J, Harada H, Fukui M, Yamada S, Kato Y. Epitope Mapping of the Antihorse Podoplanin Monoclonal Antibody PMab-202. Monoclonal antibodies in immunodiagnosis and immunotherapy. 2019.04; 38 (2): 79-84. ( PubMed, DOI )

230. Furusawa Y, Kaneko MK, Nakamura T, Itai S, Fukui M, Harada H, Yamada S, Kato Y. Establishment of a Monoclonal Antibody PMab-231 for Tiger Podoplanin. Monoclonal antibodies in immunodiagnosis and immunotherapy. 2019.04; 38 (2): 89-95. ( PubMed, DOI )

231. Higuchi Y, Tsushima F, Sumikura K, Sato Y, Harada H, Kayamori K, Ikeda T. Diagnosis and treatment of oral focal mucinosis: a case series. Journal of medical case reports. 2019.04; 13 (1): 108. ( PubMed, DOI )

232. Ishida S, Kayamori K, Sakamoto K, Yukimori A, Kugimoto T, Harada H, Ikeda T.. Alpha-L-fucosidase-1 is a diagnostic marker that distinguishes mucoepidermoid carcinoma from squamous cell carcinoma. Pathol Int.. 2019.02;

233. Yoshikazu F, Shinji Y, Shunsuke I, Takuro N, Miyuki Y, Masato S, Hiroyuki H, Masato F, Mika K.K, Yukinari K. A monoclonal antibody for the immunohistochemical analysis of horse podoplanin Biochem Biophys Rep.. 2019.02; (18): 100616.

234. Yoshikazu F, Shinji Y, Shunsuke I, Masato S, Takuro N, Miyuki Y, masato F, Hiroyuki H, Takuya M, Yusuke S, Masaki T, Mika K.K, Yukinari K. A Monoclonal Antibody Against Pig Podoplanin Monoclon. Antib. Immunodiagn. Immunother.. 2019.02; 38 (1): 30-36.

235. Ishida Shoko, Kayamori Kou, Sakamoto Kei, Yukimori Akane, Kugimoto Takuma, Harada Hiroyuki, Ikeda Tohru. Alpha-L-fucosidase-1は扁平上皮癌と粘表皮癌を識別する診断マーカーである(Alpha-L-fucosidase-1 is a diagnostic marker that distinguishes mucoepidermoid carcinoma from squamous cell carcinoma) Pathology International. 2019.02; 69 (2): 76-85. ( 医中誌 )

236. Furusawa Y, Yamada S, Itai S, Sano M, Nakamura T, Yanaka M, Fukui M, Harada H, Mizuno T, Sakai Y, Takasu M, Kaneko MK, Kato Y. PMab-210: A Monoclonal Antibody Against Pig Podoplanin. Monoclonal antibodies in immunodiagnosis and immunotherapy. 2019.02; 38 (1): 30-36. ( PubMed, DOI )

237. Kato Y, Yamada S, Furusawa Y, Itai S, Nakamura T, Yanaka M, Sano M, Harada H, Fukui M, Kaneko MK. PMab-213: A Monoclonal Antibody for Immunohistochemical Analysis Against Pig Podoplanin. Monoclonal antibodies in immunodiagnosis and immunotherapy. 2019.02; 38 (1): 18-24. ( PubMed, DOI )

238. Fukuda S, Akiyama M, Harada H, Nakahama KI.. Effect of gap junction-mediated intercellular communication on TGF-β induced epithelial-to-mesenchymal transition. Biochem Biophys Res Commun.. 2019.01; 508 (3): 928-933. ( DOI )

239. Takada Kaho, Kuroshima Takeshi, Shimamoto Hiroaki, Ohsako Toshimitsu, Kayamori Kou, Ikeda Tohru, Harada Hiroyuki. Metastasis of lower gingival squamous cell carcinoma to buccinator lymph node: case report and review of the literature WORLD JOURNAL OF SURGICAL ONCOLOGY. 2019.01; 17 (1): 13. ( PubMed, DOI )

240. Shimizu R, Tanaka K, Oikawa Y, Tomioka H, Kayamori K, Ikeda T, Yoshioka T, Ebihara A, Harada H. Epithelioid cell granuloma with caseating necrosis possibly caused by periapical periodontitis: a case report. Journal of Medical Case Reports.. 2018.12; 12 (1): 365-370. ( PubMed, DOI )

241. Takahashi Y, Tanaka K, Hirai H, Marukawa E, Izumo T, Harada H. Appropriate surgical margin for odontogenic myxoma: a review of 12 cases. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology. 2018.11; 126 (5): 404-408. ( DOI )

242. Yamada S, Itai S, Furusawa Y, Sano M, NakamuraT, Yanaka M, Handa S, Hisamatsu K, Nakamura Y, Fukui M, Harada H, Mizuno T, Sakai Y, Ogasawara S, Murata T, Uchida H, Tahara H, Kaneko MK, Kato Y. Detection of tiger podoplanin using the anti-cat podoplanin monoclonal antibody PMab-52 Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 2018.11; 37 (5): 224-228. ( PubMed, DOI )

243. Furusawa Y, Yamada S, Itai S, Sano M, Nakamura T, Yanaka M, Handa S, Mizuno T, Maeda K, Fukui M, Harada H, Kaneko MK, Kato Y. Establishment of Monoclonal Antibody PMab-202 against Horse Podoplanin Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 2018.11; 37 (5): 233-237. ( PubMed, DOI )

244. Mochizuki Y, Harada H, Yokokawa M, Kinoshita N, Kubota K, Okado T, Fukayama H. Oral and maxillofacial surgery in patients undergoing dialysis for advanced renal disease: report of five cases. BMC Oral Health. 2018.10; 18 (1): 166-175. ( PubMed, DOI )

245. Ngamsom S, Nakamura S, Kabasawa Y, Harada H, Tohyama R, Kurabayashi T. Imaging findings of intraosseous traumatic neuroma of the mandible Oral radiology. 2018.09; 34 (3): 257-261. ( DOI )

246. Itai S, Yamada S, Kaneko MK, Sano M, Nakamura T, Yanaka M, Handa S, Hisamatsu K, Nakamura Y, Furusawa Y, Fukui M, Ohishi T, Kawada M, Harada H, Kato Y. Podocalyxin is crucial for the growth of oral squamous cell carcinoma cell line HSC-2 Biochem Biophys Rep. 2018.09; 15 93-96. ( PubMed, DOI )

247. Kaneko MK, Yamada S, Itai S, Furusawa S, Nakamura T, Yanaka M, Handa S, Hisamatsu K, Nakamura Y, Fukui M, Harada H, Kato Y. Epitope mapping of an anti-alpha thalassemia/mental retardation syndrome Xlinked monoclonal antibody AMab-6 Biochem Biophys Rep. 2018.09; 15 76-80. ( PubMed, DOI )

248. Yamada I, Yoshino N, Hikishima K, Sakamoto J, Yokokawa M, Oikawa Y, Harada H, Kurabayashi T, Saida Y, Tateishi U, Yukimori A, Izumo T, Asahina S. Oral carcinoma: Clinical evaluation using diffusion kurtosis imaging and its correlation with histopathologic findings Magnetic Resonance Imaging. 2018.09; 51 69-78. ( PubMed, DOI )

249. Ngamsom Supak, Nakamura Shin, Kabasawa Yuji, Harada Hiroyuki, Tohyama Rei, Kurabayashi Tohru. 下顎骨内に発生した外傷性神経腫の画像所見(Imaging findings of intraosseous traumatic neuroma of the mandible) Oral Radiology. 2018.09; 34 (3): 257-261. ( 医中誌 )

250. Ngamsom S, Nakamura S, Kabasawa Y, Harada H, Tohyama R, Kurabayashi T. Imaging findings of intraosseous traumatic neuroma of the mandible. Oral radiology. 2018.09; 34 (3): 257-261. ( PubMed, DOI )

251. Matsui T, Okada T, Kawada K, Okuda m, Ogo T, Nakajima Y, Kume Y, Ryotokuji T, Hoshino A, Tokairin Y, Michi Y, Harada H, Nakajima Y, Kawano T. Detection of second primary malignancies of the esophagus and hypophraynx in oral squamous cell carcinoma patients Laryngoscope Investigative Otolaryngology. 2018.08; 3 (4): 263-267. ( DOI )

252. Yamaga E, Toriihara A, Nakamura S, Asai S, Fujioka T, Yoshimura R, Michi Y, Harada H, Tateishi U. Clinical usefulness of 2-deoxy-2-[18F] fluoro-D-glucose-positron emission tomography/computed tomography for assessing early oral squamous cell carcinoma (cT1-2N0M0) Japanese Journal of Clinical Oncology. 2018.07; 48 (7): 633-639. ( DOI )

253. Shimada Y, Kawasaki Y, Tayama M, Kindaichi J, Maruoka Y. A case of central odontogenic fibroma of the mandible in a nevoid basal cell carcinoma syndrome patient Oral Science International. 2018.07; 15 (2): 61-67. ( DOI )

254. Yamaga Emi, Toriihara Akira, Nakamura Shin, Asai Sakurako, Fujioka Tomoyuki, Yoshimura Ryoichi, Michi Yasuyuki, Harada Hiroyuki, Tateishi Ukihide. 2-deoxy-2-[18F]fluoro-D-glucoseを用いたPET/CTによる早期口腔扁平上皮癌(cT1-2N0M0)評価の臨床有用性(Clinical usefulness of 2-deoxy-2-[18F] fluoro-D-glucose-positron emission tomography/computed tomography for assessing early oral squamous cell carcinoma(cT1-2NOMO)) Japanese Journal of Clinical Oncology. 2018.07; 48 (7): 633-639. ( 医中誌 )

255. Yamada S, Kaneko MK, Itai S, Chang YW, Nakamura T, Yanaka M, Ogasawara S, Murata T, Uchida H, Tahara H, Harada H, Kato Y. Epitope Mapping of Monoclonal Antibody PMab-48 against Dog Podoplanin. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 2018.06; 37 (3): 162-165. ( PubMed, DOI )

256. Ohata Y, Kayamori K, Yukimori A, Sumikura K, Ohsako T, Harada H, Sakamoto K, Ikeda T. A lesion categorized between ghost cell odontogenic carcinoma and dentinogenic ghost cell tumor with CTNNB1 mutation. Pathology International. 2018.05; 68 (5): 307-312. ( PubMed, DOI )

257. Miyazaki H, Ohshiro T, Romeo U, Noguchi T, Maruoka Y, Gaimari G, Tomov G, Wada Y, Tanaka K, Ohshiro T, Asamura S. Retrospective Study on Laser Treatment of Oral Vascular Lesions Using the "Leopard Technique": The Multiple Spot Irradiation Technique with a Single-Pulsed Wave Photomed Laser Surgery. 2018.05; 36 (6): 320-325. ( PubMed )

258. Furusawa Y, Yamada Y, Itai S, Nakamura T, Fukui M, Harada H, Kaneko MK, Kato Y. Elucidation of critical epitope mapping of anti-rat podoplanin monoclonal antibody PMab-2 Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 2018.05; 37 (4): 188-193. ( PubMed, DOI )

259. Kaneko MK, Yamada S, Itai S, Chang YW, Nakamura T, Yanaka M, Harada H, Suzuki H, Kato Y. Elucidation of The TMab-6 Monoclonal Antibody Epitope Against Telomerase Reverse Transcriptase. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 2018.05; 38 (3): 101-103. ( PubMed, DOI )

260. Ohata Yae, Kayamori Kou, Yukimori Akane, Sumikura Kanako, Ohsako Toshimitsu, Harada Hiroyuki, Sakamoto Kei, Ikeda Tohru. CTNNB1変異を伴う幻影細胞性歯原性癌と象牙質形成性幻影細胞腫間に分類された病変(A lesion categorized between ghost cell odontogenic carcinoma and dentinogenic ghost cell tumor with CTNNB1 mutation) Pathology International. 2018.05; 68 (5): 307-312. ( 医中誌 )

261. Itai S, Ohishi T, Kaneko MK, Yamada S, Abe S, Nakamura T, Yanaka M, Chang YW, Ohba S, Nishioka Y, Kawada M, Harada H, Kato Y. Anti-podocalyxin antibody exerts antitumor effects via antibody-dependent cellular cytotoxicity in mouse xenograft models of oral squamous cell carcinoma. Oncotarget. 2018.04; 9 (32): 22480-22497. ( PubMed, DOI )

262. Sato M, Harada H, Nagata C, Suzuki K. A case of Ectomesenchymal Chondromyxoid Tumor on the tongue Journal of Oral and Maxillofacial Surgery, Medicine. 2018.03; 30 (2): 134-137. ( DOI )

263. Nishii N, Tachinami H, Kondo Y, Xia Y, Kashima Y, Ohno T, Nagai S, Li L, Lau W, Harada H, Azuma M. Systemic administration of a TLR7 agonist attenuates regulatory T cells by dendritic cell modification and overcomes resistance to PD-L1 blockade therapy. Oncotarget. 2018.03; 9 (17): 13301-13312. ( PubMed, DOI )

264. Ando Kentaro, Nakamura Yuji, Hagiwara-Nagasawa Mihoko, Harada Hiroyuki, Miyamoto Hiroyoshi, Inamura Naoki, Takagi Kan, Goto Ai, Chiba Koki, Lubna Nur Jaharat, Izumi-Nakaseko Hiroko, Naito Atsuhiko T., Sugiyama Atsushi. テルフェナジンの薬力学的および薬物動態学的プロファイルの変動ならびにその活性誘導体であるフェキソフェナジンのトルサード・ド・ポワント誘導リスクについて検討するための、ハロタン麻酔イヌを対象としたクロスオーバー試験によるテルフェナジンとフェキソフェナジンの電気薬理学的作用の比較(Comparison of electropharmacological effects between terfenadine and its active derivative fexofenadine using a cross-over study in halothane-anesthetized dogs to analyze variability of pharmacodynamic and pharmacokinetic profiles of terfenadine and torsadogenic risk of fexofenadine) The Journal of Toxicological Sciences. 2018.03; 43 (1-3): 183-192. ( 医中誌 )

265. Sato Masaru, Harada Hiroyuki, Nagata Chigusa, Suzuki Keiko. 舌のectomesenchymal chondromyxoid tumorの1例(A case of ectomesenchymal chondromyxoid tumor of the tongue) Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology. 2018.03; 30 (2): 134-137. ( 医中誌 )

266. Ohata Y, Tsuchiya M, Hirai H, Yamaguchi S, Akashi T, Sakamoto K, Yamaguchi A, Ikeda T, Kayamori K. Leukemia inhibitory factor produced by fibroblasts within tumor stroma participates in invasion of oral squamous cell carcinoma PLoS One. 2018.02; e0191865.

267. Jiaranuchart S, Kaida A, Onozato Y, Harada H, Miura M. DNA damage response following X-irradiation in oral cancer lines HSC3 and HSC4 Archives of Oral Biology. 2018.02; 90 1-8. ( PubMed, DOI )

268. Kuroshima T, Wada M, Sato T, Takano M, and Makino S. G-CSF producing oral carcinoma with diffuse uptake of FDG in the bone marrow: A case report Oncology Letters. 2018.01; 15 (1): 1241-1245.

269. Nishii N, Tachinami H, Kondo Y, Xia Y, Kashima Y, Ohno T, Nagai S, Li L, Lau W, Harada H, Azuma M. Systemic administration of a TLR7 agonist attenuates regulatory T cells by dend+E11:AB11ritic cell modification and overcomes resistance to PD-L1 blockade therapy Oncotarget. 2018.01; 9 13301-13312. ( DOI )

270. Takemoto T, Kabasawa Y, Higuchi Y, Tabata Y, Aoki K, Tamura Y, Harada H. Combination of the RANKL-binding peptide W9 and bFGF induces ectopic bone regeneration in the rat calvarial defect mode Dental, Oral and Craniofacial Research. 2017.12; 4 (3): 2-7. ( DOI )

271. Harada H, Suehiro S, Murakami D, Nakahara R, Ujihara T, Shimizu T, Miyama Y, Katsuyama Y, Hayasaka K, Tounou S. Clinical impact of prophylactic clip closure of mucosal defects after colorectal endoscopic submucosal dissection. Endoscopy international open. 2017.12; 5 (12): E1165-E1171. ( PubMed, DOI )

272. Harada Hiroyuki, Shinohara Shogo, Takebayashi Shinji, Kikuchi Masahiro, Fujiwara Keizo, Michida Tetsuhiko, Yamamoto Ryosuke, Hayashi Kazuki, Saida Koji, Naito Yasushi. アルコール摂取後の顔面潮紅は上部消化管癌の同時性または異時性リスクが高いことの予測因子である(Facial flushing after alcohol intake as a predictor for a high risk of synchronous or metachronous cancer of the upper gastrointestinal tract) Japanese Journal of Clinical Oncology. 2017.12; 47 (12): 1123-1128. ( 医中誌 )

273. Itai S, Yamada S, Kaneko MK, Harada H, Kagawa Y, Konnai S, Kato Y. Expression of Cat Podoplanin in Feline Squamous Cell Carcinomas. Monoclonal antibodies in immunodiagnosis and immunotherapy. 2017.12; 36 (6): 243-250. ( PubMed, DOI )

274. マハムド・エルバシュティ , アメル・アスウェヘリー , 服部 麻里子, 隅田 由香, 道 泰之, 鵜澤 成一, 山口 聡, 原田 浩之, 谷口 尚. 上顎切除患者に対する顎顔面補綴治療上の考慮事項に関する外科医の意識調査(Surgeons' Awareness of the Considerations for Prosthetic Rehabilitation in Maxillectomy Patients) 顎顔面補綴. 2017.12; 40 (2): 28-36. ( 医中誌 )

275. Itai S, Yamada S, Kaneko MK, Chang YW, Harada H, Kato Y. Establishment of EMab-134, a Sensitive and Specific Anti-Epidermal Growth Factor Receptor Monoclonal Antibody for Detecting Squamous Cell Carcinoma Cells of the Oral Cavity. Monoclonal antibodies in immunodiagnosis and immunotherapy. 2017.12; 36 (6): 272-281. ( PubMed, DOI )

276. Yamada S, Itai S, Nakamura T, Chang YW, Harada H, Suzuki H, Kaneko MK, Kato Y. Establishment of H(2)Mab-119, an Anti-Human Epidermal Growth Factor Receptor 2 Monoclonal Antibody, Against Pancreatic Cancer. Monoclonal antibodies in immunodiagnosis and immunotherapy. 2017.12; 36 (6): 287-290. ( PubMed, DOI )

277. Itai S, Yamada S, Kaneko MK, Harada H, Kagawa Y, Konnai S, Kato Y. Expression of cat podoplanin in feline squamous cell carcinomas Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 2017.11; ( DOI )

278. Yamada S, Itai S, Nakamura T, Chang YW, Harada H, Suzuki H, Kaneko MK, Kato Y. Establishment of H2Mab-119, an Anti-Human Epidermal Growth Factor Receptor 2 Monoclonal Antibody, Against Pancreatic Cancer Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 2017.11; ( DOI )

279. Itai S, Yamada S, Kaneko MK, Chang YW, Harada, H, Kato Y. Establishment of EMab-134, a sensitive and specific anti-epidermal growth factor receptor monoclonal antibody for detecting squamous cell carcinoma cells of the oral cavity Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 2017.11; ( DOI )

280. Ohata Y, Tatsuzawa A, Ohyama Y, Ichikawa A, Mochizuki Y, Ishibashi S, Itakura Y, Sakamoto K, Ikeda T, Kitagawa M, Yamamoto K. A distinctive subgroup of oral EBV+ B-cell neoplasm with polymorphous features is potentially identical to EBV+ mucocutaneous ulcer Human Pathology. 2017.11; 69 129-139. ( DOI )

281. Itai S, Kaneko MK, Fujii Y, Yamada S, Nakamura T, Yanaka M, Saidoh N, Handa S, Chang YW, Suzuki H, Harada H, Kato Y. Development of EMab-51, a Sensitive and Specific Anti-EGFR Monoclonal Antibody in Western Blot and Immunohistochemistry Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 2017.10; 36 (5): 214-219. ( PubMed, DOI )

282. Yamagata Y, Tomioka H, Sakamoto K, Sato K, Harada H, Ikeda T, Kayamori K. CD163-Positive Macrophages Within the Tumor Stroma Are Associated With Lymphangiogenesis and Lymph Node Metastasis in Oral Squamous Cell Carcinoma J Oral Maxillofac Surg. 2017.10; 75 (10): 2144-2153. ( DOI )

283. Yamada S, Itai S, Nakamura T, Yanaka M, Saidoh N, Chang YW, Handa S, Harada H, Kagawa Y, Ichii O, Konnai S, Kaneko MK, Kato Y. PMab-52: Specific and Sensitive Monoclonal Antibody Against Cat Podoplanin for Immunohistochemistry Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 2017.10; ( DOI )

284. Itai S, Yamada S, Kaneko MK, Harada H, Kato Y. Immunohistochemical Analysis Using Antipodocalyxin Monoclonal Antibody PcMab-47 Demonstrates Podocalyxin Expression in Oral Squamous Cell Carcinomas Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 2017.10; ( DOI )

285. Itai S, Fujii Y, Nakamura T, Chang YW, Yanaka M, Saidoh N, Handa S, Suzuki H, Harada H, Yamada S, Kaneko MK, Kato Y. Establishment of CMab-43, a Sensitive and Specific Anti-CD133 Monoclonal Antibody, for Immunohistochemistry. Monoclonal antibodies in immunodiagnosis and immunotherapy. 2017.10; 36 (5): 231-235. ( PubMed, DOI )

286. Itai S, Yamada S, Kaneko MK, Harada H, Kato Y. Immunohistochemical Analysis Using Antipodocalyxin Monoclonal Antibody PcMab-47 Demonstrates Podocalyxin Expression in Oral Squamous Cell Carcinomas. Monoclonal antibodies in immunodiagnosis and immunotherapy. 2017.10; 36 (5): 220-223. ( PubMed, DOI )

287. Yamada S, Itai S, Nakamura T, Yanaka M, Saidoh N, Chang YW, Handa S, Harada H, Kagawa Y, Ichii O, Konnai S, Kaneko MK, Kato Y. PMab-52: Specific and Sensitive Monoclonal Antibody Against Cat Podoplanin for Immunohistochemistry. Monoclonal antibodies in immunodiagnosis and immunotherapy. 2017.10; 36 (5): 224-230. ( PubMed, DOI )

288. Ngansom S, Nakamura S, Kabasawa Y, Harada H, Tohyama R, Kurabayashi T. Imaging findings of intraosseous traumatic neuroma of the mandible Oral Radiology. 2017.09;

289. Hirai H, Tomioka H, Mochizuki Y, Oikawa Y, Tsushima F, Harada H. Clinical Course of Oral Squamous Cell Carcinoma in Patients on Immunosuppressant and Glucocorticoid Therapy J Oral Maxillofac Surg. 2017.09; 75 (9): 1980-1986. ( PubMed, DOI )

290. Takahara N, Nakagawa S, Sumikura K, Kabasawa Y, Sakamoto I, Harada H. Association of TMJ pain according to magnetic resonance imaging findings in TMD patients J Oral Maxillofac Surg. 2017.09; 75 (9): 1848-1855. ( PubMed, DOI )

291. Itai S, Fujii Y, Kaneko MK, Yamada S, Nakamura T, Yanaka M, Saidoh N, Chang YW, Handa S, Takahashi M, Suzuki H, Harada H, Kato Y. H2Mab-77 is a sensitive and specific anti-HER2 monoclonal antibody against breast cancer Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 2017.08; ( DOI )

292. Nakano T, Ogasawara S, Tanaka T, Hozumi Y, Mizuno S, Satoh E, Sakane F, Okada N, Taketomi A, Honma R, Nakamura T, Saidoh N, Yanaka M, Itai S, Handa S, Chang YW, Yamada S, Kaneko MK, Kato Y, Goto K. DaMab-2: Anti-Human DGK Monoclonal Antibody for immunocytochemistry Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 2017.08; ( DOI )

293. Kaneko MK, Kunita A, Yamada S, Nakamura T, Yanaka M, Saidoh N, Chang YW, Handa S, Ogasawara S, Ohishi T, Abe S, Itai S, Harada H, Kawada M, Nishioka Y, Fukayama M, Kato Y. Anti-Podocalyxin Antibody chPcMab-47 Exerts Antitumor Activity in Mouse Xenograft Models of Colorectal Adenocarcinomas Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 2017.08; ( DOI )

294. Kaneko MK, Kunita A, Yamada S, Nakamura T, Yanaka M, Saidoh N, Chang YW, Handa S, Ogasawara S, Ohishi T, Abe S, Itai S, Harada H, Kawada M, Nishioka Y, Fukayama M, Kato Y. Antipodocalyxin Antibody chPcMab-47 Exerts Antitumor Activity in Mouse Xenograft Models of Colorectal Adenocarcinomas. Monoclonal antibodies in immunodiagnosis and immunotherapy. 2017.08; 36 (4): 157-162. ( PubMed, DOI )

295. Itai S, Fujii Y, Kaneko MK, Yamada S, Nakamura T, Yanaka M, Saidoh N, Chang YW, Handa S, Takahashi M, Suzuki H, Harada H, Kato Y. H(2)Mab-77 is a Sensitive and Specific Anti-HER2 Monoclonal Antibody Against Breast Cancer. Monoclonal antibodies in immunodiagnosis and immunotherapy. 2017.08; 36 (4): 143-148. ( PubMed, DOI )

296. Shimamoto H, Oikawa Y, Osako T, Hirai H, Mochizuki Y, Tanaka K, Tomioka H, Harada H. Neck failure after elective neck dissection in patients with oral squamous cell carcinoma Oral Surg Oral Med Oral Pathol Oral Radiol. 2017.07; 124 (1): 32-36. ( DOI )

297. Hihara H, Kanetaka H, Kanno A, Koeda S, Nakasato N, Kawashima R, Sasaki K. Evaluating age-related change in lip somatosensation using somatosensory evoked magnetic fields PLOS One. 2017.06; 12 (6):

298. Mochizuki Y, Harada H, Shimamoto H, Tomioka H, Hirai H. Multiple Free Flap Reconstructions of Head and Neck Defects Due to Oral Cancer Plast Reconstr Surg Glob Open. 2017.06; 5 (6): e1337. ( PubMed, DOI )

299. Yukimori A, Oikawa Y, Morita KI, Nguyen CTK, Harada H, Yamaguchi S, KayamoriK, Yamaguchi A, Ikeda T, Sakamoto K. Genetic basis of calcifying cysticodontogenic tumors PLoS One. 2017.06; 12 (6): e0180224. ( PubMed, DOI )

300. Shinohara Shogo, Suehiro Atsushi, Kikuchi Masahiro, Harada Hiroyuki, Kishimoto Ippei, Imai Yukihiro. 喉頭の再発扁平上皮癌と共存した類腱腫の一症例(A case of desmoid tumor co-existing with recurrent squamous cell carcinoma in the larynx) Auris・Nasus・Larynx. 2017.06; 44 (3): 365-369. ( 医中誌 )

301. Harada H, Suehiro S, Murakami D, Shimizu T, Nakahara R, Katsuyama Y, Miyama Y, Tounou S, Hayasaka K. Continuous use of low-dose warfarin for gastric endoscopic submucosal dissection: a prospective study. Endoscopy international open. 2017.05; 5 (5): E348-E353. ( PubMed, DOI )

302. Onozato Y, Kaida A, Harada H, Miura M. Radiosensitivity of quiescent and proliferating cells grown as multicellular tumor spheroids Cancer Science. 2017.04;

303. Onozato Yusuke, Kaida Atsushi, Harada Hiroyuki, Miura Masahiko. 多細胞性腫瘍スフェロイドとして生育した静止細胞および増殖細胞の放射線感受性(Radiosensitivity of quiescent and proliferating cells grown as multicellular tumor spheroids) Cancer Science. 2017.04; 108 (4): 704-712. ( 医中誌 )

304. Nguyen CT，Okamura T， Morita K，Yamaguchi S，Harada H，Miki Y，Izumo T，Kayamori K，Yamaguchi A，Sakamoto K. LAMC2 is a predictive marker for the malignant progression of leukoplakia Journal of Oral Pathology and Medicine. 2017.03; 46 (3): 223-231. ( PubMed, DOI )

305. Oikawa Y，Morita K，Kayamori K，Tanimoto K，Sakamoto K，Katoh H，Ishikawa S，Inazawa J，Harada H. Receptor tyrosine kinase amplification is predictive of distant metastasis in patients with oral squamous cell carcinoma Cancer Science. 2017.02; 108 (2): 256-266.

306. Shimada Y, Nakagawa Y, Ide K, Sato I, Hagiwara S, Yamada H, Kawasaki Y, Maruoka Y. Clinical importance of elimination of potential dental focal infection before the first cycle of chemotherapy in patients with hematologic malignancy. Support Care Cancer. 2017.02; ( DOI )

307. Oikawa Yu, Morita Kei-ichi, Kayamori Kou, Tanimoto Kousuke, Sakamoto Kei, Katoh Hiroto, Ishikawa Shumpei, Inazawa Johji, Harada Hiroyuki. 口腔扁平上皮癌患者では受容体チロシンキナーゼの増幅により遠隔転移が予測される(Receptor tyrosine kinase amplification is predictive of distant metastasis in patients with oral squamous cell carcinoma) Cancer Science. 2017.02; 108 (2): 256-266. ( 医中誌 )

308. Kaneko MK，Nakamura T，Honma R，Ogasawara S，Fujii Y，Abe S，Takagi M，Harada H，Suzuki H，Nishioka Y，Kato Y. Development and characterization of anti-glycopeptide monoclonal antibodies against human podoplanin using glycan-deficient cell lines generated by CRISPR/Cas and TALEN Cancer Medicine. 2017.01; 6 (2): 382-396. ( PubMed, DOI )

309. Takahara N，Kabasawa Y，Sato M，Tetsumura A，Kurabayashi T，Omura K. MRI Changes of　temporomandibular joint following mandibular setback using sagittal split ramus osteotomy with rigid fixation The Journal of Craniomandibular & Sleep Practice. 2017.01; 35 (11): 38-45. ( DOI )

310. Lam PD, Kuribayashi A, Sakamoto J, Nakamura S, Harada H, Kurabayashi T. Imaging findings of childhood B-cell lymphoblastic lymphoma in the mental region: a case report. Dentomaxillofacial Radiology. 2017; 46 (3): 20160313. ( PubMed, DOI )

311. Marukawa E，Tamai M，Takahashi Y，Hatakeyama I，Sato M，Higuchi Y，Kakidachi H，Taniguchi H，Sakamoto T，Honda J，Omura K，Harada H. Comparison of magnesium alloys and poly-l-lactide screws as degradable implants in a canine fracture model Journal of Biomedical Materials Research Part B: Applied Biomaterials. 2016.10; 104 (7): 1282-1289.

312. Shimada Y，Maruoka Y，Yamaji I，Kawai S. Non-syndromic familial keratocystic odontogenic tumour: a rare case report in Japanese identical twins. J Clin Diagn Res. 2016.08; 10 (8): ZD28-ZD30.

313. Macedo R，Rochefort J，Guillot-Delost M，Tanaka K，Le Moignic A，Noizat C，Baillou C，Mateo V，Carpentier AF，Tartour E，Bertolus C，Bellier B，Lescaille G，Lemoine FM. Intra-cheek immunization as a novel vaccination route for therapeutic vaccines of head and neck squamous cell carcinomas using plasmo virus-like particles Oncoimmunology. 2016.07; 5 (7): e1164363. ( DOI )

314. Tohyama R，Kayamori K，Sato K，Hamagaki M，Sakamoto K，Yasuda H，Yamaguchi A. Establishment of a xenograft model to explore the mechanism of bone destruction by human oral cancers and its application to analysis of role of RANKL Journal of Oral Pathology & Medicine. 2016.05; 45 (5): 356-364.

315. Kohmoto T，Tsuji A，Morita K，Naruto T，Masuda K，Kashimada K，Enomoto K，Morio T，Harada H，Imoto I. A novel COL11A1 missense mutation in siblings with non-ocular Stickler syndrome Human Genome Variation. 2016.04; 2016 (3): 16003. ( DOI )

316. Kayamori K，Katsube K，Sakamoto K，Ohyama Y，Hirai H，Yukimori A，Ohata Y，Akashi T，Saitoh M，Harada K，Harada H，Yamaguchi A. NOTCH3 Is Induced in Cancer-Associated Fibroblasts and Promotes Angiogenesis in Oral Squamous Cell Carcinoma PLoS One. 2016.04; 11 (4): e0154112. ( DOI )

317. Shirakawa J，Harada H，Noda M，Ezura Y. PTH-Induced Osteoblast Proliferation Requires Upregulation of the Ubiquitin-Specific Peptidase 2 (Usp2) Expression Calcified Tissue International. 2016.03; 98 (3): 306-315.

318. Oda S，Nozawa T，Nozawa-Minowa A，Tanaka M，Aikawa C，Harada H，Nakagawa I. Golgi-Resident GTPase Rab30 Promotes the Biogenesis of Pathogen-Containing Autophagosomes PLoS One. 2016.01; 11 (1): e0147061. ( DOI )

319. Kato Y，Ogasawara S，Oki H，Honma R，Takagi M，Fujii Y，Nakamura T，Saidoh N，Kanno H，Umetsu M，Kamata S，Kubo H，Yamada M，Sawa Y，Morita K，Harada H，Suzuki H，Kaneko MK. Novel Monoclonal Antibody LpMab-17 Developed by CasMab Technology Distinguishes Human Podoplanin from Monkey Podoplanin Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 2016; 2 (35): 109-116.

320. Mochizuki Y，Tomioka H，Tsushima F，Shimamoto H，Oikawa Y，Harada H. Clinical evaluation of the coverage of open wounds in the oral surgical field with a polyglycolic acid sheet and a fibrin glue spray and coverage with split thickness skin grafting Annals Maxillofacial Surgery. 2016; 6 (2): 228-234.

321. Kondo Y，Ohno T，Nishii N，Harada K，Yagita H，Azuma M. Differential contribution of three immune checkpoint (VISTA, CTLA-4, PD-1) pathways to antitumor responses against squamous cell carcinoma Oral Oncology. 2016; 57 54-60.

322. Dilruba Aktar，Tomioka H，Hirai H，Oikawa Y，Mochizuki Y，Shimamoto H，Harada H. Value of real-time tissue elastography for squamous cell carcinoma of the tongue Dental，Oral and Craniofacial Research. 2016; 2 (6): 371-375.

323. Ohata Y，Tohyama R，Kayamori K，Shimamoto H，Hirota Y，Harada H，Izumo T，Sakamoto K. A rare cancer of the tongue that demonstrated unusual histology and immunohistochemical phenotype: case report International Dentistry Scientific Meeting 2016/UI Proceedings on Health and Medicine. 2016; 1 (1): 172-175. ( DOI )

324. Masaru S，Morita K，Kabasawa Y，Harada H. Bilateral nasolabial cysts: a case report Jounal of Medical case Reports. 2016; 10 246. ( DOI )

325. Masanori Kudoh, Ken Omura, Arata Satsukawa, Koshi Matsumoto, Takahide Taguchi, Hiroyuki Harada, Yoshimasa Ishii. Symmetric Lipomatosis Arising in the Tongue Presenting as Macroglossia and Articulatory Disorder Case Reports in Otolaryngology. 2016; (2016): ( DOI )

326. Kudoh M, Harada H, Sato Y, Omura K, Ishii Y. Massive odontoameloblastoma arising in the maxilla: a case report. J Medical Case Rep. 2015.12; 9 278. ( PubMed, DOI )

327. Fukuda S, Hayashi R, Nishimura Y, Nakamizo M, Ota Y, Chazono H , Nakamura K, Harada H, Fujimoto Y, Yoshimoto S. Report of fead and neck cancer registry of Japan clinical statistics of registered patients, 2013. Japanese Journal of Head and Neck Cancer. 2015.11; 41 (supplement):

328. Kuribayashi Y, Tsushima F, Morita K, Matsumoto K, Sakurai J, Uesugi A, Sato K, Oda S, Sakamoto K, Harada H. Long-term outcome of non-surgical treatment in patients with oral leukoplakia. Oral Oncol. 2015.11; 51 (11): 1020-1025. ( PubMed, DOI )

329. Morita K, Naruto T, Tanimoto K, Yasukawa C, Oikawa Y, Masuda K, Imoto I, Inazawa J, Omura K, Harada H. Simultaneous detection of both single nucleotide variations and copy number alterations by next-generation sequencing in gorlin syndrome. PLOS One. 2015.11; 10 (11): e0140480. ( PubMed, DOI )

330. Tsushima F, Sakurai J, Harada H. A case of upper gingiva carcinoma with chronic graft-versus-host disease after allogenic bone marrow transplantation. Aust Dent J. 2015.09; 60 (3): 404-407.

331. Kudo M, Harada H, Matsumoto K, Sato Y, Omura K, Ishii Y. Massive neurilemoma of the hard plate in which preoperative diagnosis was difficult. Case Rep Surg. 2015.08; 2015 638025. ( DOI )

332. Mochizuki Y, Harada H, Sakamoto K, Kayamori K, Nakamura S, Ikuta M, Kabasawa Y, Marukawa E, Shimamoto H, Tushima F, Omura K. Malignant lymphoma with initial symptoms in the mandibular region. J Cancer Ther. 2015.07; 6 (7): 554-565.

333. Tomioka H, Kaneoya A, Mochizuki Y, Harada H. Primary diffuse large B-cell lymphoma arising in the tongue accompanied by ataxia-telangiectasia: a case report. J Clin Diagn Res. 2015.06; 9 (6): ZD25-ZD27. ( PubMed, DOI )

334. Mochizuki Y, Harada H, Ikuta M, Shimamoto H, Tomioka H, Tanaka K, Hirai H, Omura K. Clinical characteristics of multiple primary carcinomas of the oral cavity. Oral Oncol. 2015.02; 51 (2): 182-189.

335. Harada H, Omura K.. Preoperative concurrent chemotherapy with S-1 and radiotherapy for locally advanced squamous cell carcinoma of the oral cavity: Phase I trial. J Exp Clin Cancer Res.. 2010; 20 (29): 33.

336. H Harada, K Omura.. Metastasis of oral cancer to the parotid node. Eur J Surg Oncol. 2009; 35 (8): 890-894.

337. Hiroyuki Harada, Ken Omura, Yusuke Nakajima, Shogo Hasegawa and Seiki Mogi.. Cyclin B1 is useful to predict occult cervical lymph node metastasis in tongue carcinoma. J Exp Clin Cancer Res. 2006; 25 (3): 351-356.

338. Hiroyuki Harada, Ken Omura, Yosuke Takeuchi.. Patency and caliber of the internal jugular vein after neck dissection. Auris Nasus Larynx. 2003; 30 (3): 269-272.

339. 1) Hiroyuki Harada, Shuichi Takinami, Shujiroh Makino, Hideaki Kitada, Tomomi Yamashita, Ken-ichi Notani, Hiroshi Fukuda, Motoyasu Nakamura.. Three-phase bone scintigraphy and viability of vascularized bone grafts for mandibular reconstruction. Int J of Oral & Maxillofac Surg. 2000; 29 (4): 280-284.

340. 福田修平, 生田　稔, 吉住　結, 原田浩之. 顎骨骨折に併発した外傷性頸動脈海綿静脈洞瘻の1例 日本口腔外科学会雑誌. 2024.12; 70 (12): 520-525.

341. 黒嶋雄志, 原田浩之. 口腔癌の再発を減らす切除の工夫　口腔癌の切除における介在リンパ節に対する配慮　舌癌における舌リンパ節について 日本口腔外科学会雑誌. 2024.11; 70 (11): 470-475. ( DOI 医中誌 )

342. 佐藤百合子, 木下直哉, 道　泰之, 布川裕規, 池田　通, 原田浩之. 口腔内に発症したメトトレキサート関連リンパ増殖性疾患の臨床病理学的検討 日本口腔外科学会雑誌. 2024.10; 70 (10): 412-418.

343. 杉田好彦, 森山雅文, 津島文彦, 長谷川博雅, 河野憲司, 中村誠司, 前田初彦, 岩渕博史, 安彦善裕, 菅原由美子, 伊東大典, 川又　均, 日本口腔内科学会第二期口腔扁平苔癬ワーキンググループ. 口腔扁平苔癬研究の現況と将来の展望 日本口腔内科学会雑誌. 2024.06; 30 (1): 1-12. ( DOI 医中誌 )

344. Kayamori Kou, Katsube Ken-ichi, Hirai Hideaki, Harada Hiroyuki, Ikeda Tohru. Role of Stromal Fibroblast-Induced WNT7A Associated with Cancer Cell Migration Through the AKT/CLDN1 Signaling Axis in Oral Squamous Cell Carcinoma LABORATORY INVESTIGATION. 2023.10; 103 (10): 100228. ( PubMed, DOI )

345. 山形 優子, 黒嶋 雄志, 西井 直人, 栢森 高, 池田 通, 原田 浩之. Maxillary swing approach変法で切除した上顎骨腫瘍の1例 日本口腔外科学会雑誌. 2023.06; 69 (6): 304-308. ( 医中誌 )

346. 山形優子, 黒嶋雄志, 西井直人, 栢森　高, 池田　通, 原田浩之. Maxillary swing approach 変法で切除した上顎骨腫瘍の1例 日口外誌. 2023.06; 69 (6): 304-308. ( DOI 医中誌 )

347. Okihata R, Michi Y, Sunakawa M, Tagashira Y. Pharmacist-led multi-faceted intervention in an antimicrobial stewardship programme at a dental university hospital in Japan J Hosp Infect. 2023.06; 136 30-37. ( PubMed, DOI )

348. Ikeda Naoki, Kubota Hiroaki, Suzuki Risa, Morita Mitsuki, Yoshimura Ayana, Osada Yuya, Kishida Keigo, Kitamura Daiki, Iwata Ayaka, Yotsumoto Satoshi, Kurotaki Daisuke, Nishimura Koutarou, Nishiyama Akira, Tamura Tomohiko, Kamatani Takashi, Tsunoda Tatsuhiko, Murakawa Miyako, Asahina Yasuhiro, Hayashi Yoshihiro, Harada Hironori, Harada Yuka, Yokota Asumi, Hirai Hideyo, Seki Takao, Kuwahara Makoto, Yamashta Masakatsu, Shichino Shigeyuki, Tanaka Masato, Asano Kenichi. The early neutrophil-committed progenitors aberrantly differentiate into immunoregulatory monocytes during emergency myelopoiesis CELL REPORTS. 2023.03; 42 (3): 112165. ( PubMed, DOI )

349. 清水六花, 大迫利光, 釘本琢磨, 西井直人, 津島文彦, 原田浩之. 多様な口腔症状を呈したSotos症候群の1例 日口外誌. 2023.01; 69 (1): 22-26. ( DOI 医中誌 )

350. 原田浩之. 口腔がんの手術と治療 The Way Forward（未来への挑戦）. 2022.12; 22 19-20.

351. 佐藤　昌, 伊澤和倫, 平井秀明, 原田浩之.. 顎口腔領域の転移性腫瘍6例の臨床病理学的検討. 日本口腔腫瘍学会誌. 2022.09; 34 (3): 123-129. ( DOI 医中誌 )

352. 佐藤 昌, 伊澤 和倫, 平井 秀明, 原田 浩之. 顎口腔領域の転移性腫瘍6例の臨床病理学的検討 日本口腔腫瘍学会誌. 2022.09; 34 (3): 123-129. ( 医中誌 )

353. 高坂 光, 川島 麻美, 中島 雄介, 原田 浩之, 向山 仁. 総合病院における入退院支援センターを通じた周術期口腔機能管理に関する取り組み 有病者歯科医療. 2022.05; 31 (3): 182-187. ( 医中誌 )

354. Doi Satomi, Sekiguchi Mayu, Motoya Ryo, Kanazawa Junichiro, Sato Masumi, Harada Hiroshi, Fukuzawa Nobuyuki, Wada Yoshiki, Hirano Tetsuo. Associations Between Recipients' Feelings of Guilt for Donor and Depressive Symptoms Before Living Kidney Transplantation TRANSPLANTATION PROCEEDINGS. 2022.04; 54 (3): 622-626. ( PubMed, DOI )

355. 新垣理宣, 勝良剛詞, 小林大二郎, 道　泰之, 北本佳住, 依田哲也, 倉林　亨. 頭頸部化学放射線治療後に多発う蝕を生じ口腔管理に苦慮した1例 歯科放射線. 2022.03; 61 (2): 53-57. ( DOI 医中誌 )

356. 小宮瑠里. 口腔内症状を契機に診断されたHIV感染症の1例 山梨県立中央病院年報. 2022.03; 48 160-163. ( 医中誌 )

357. 原田 浩之. 【口腔癌update】口腔癌の診断と外科治療 病理と臨床. 2022.01; 40 (1): 10-16. ( 医中誌 )

358. 遠山皓基, 加納嘉人, 野地理夏, 青柳康子, 松寺翔太郎, 大野十央, 有泉陽介, 道泰之, 富岡寛文, 島本裕彰, 吉村 亮一, 朝蔭孝宏, 原田浩之, 三宅智, 三浦雅彦, 池田貞勝. 再発・転移頭頸部癌に対する網羅的がんゲノム解析と臨床的有用性. 頭頸部癌. 2021.12; 47 (4): 359-365. ( DOI )

359. 遠山 皓基, 加納 嘉人, 野地 理夏, 青柳 康子, 松寺 翔太郎, 大野 十央, 有泉 陽介, 道 泰之, 富岡 寛文, 島本 裕彰, 吉村 亮一, 朝蔭 孝宏, 原田 浩之, 三宅 智, 三浦 雅彦, 池田 貞勝. 再発・転移頭頸部癌に対する網羅的がんゲノム解析と臨床的有用性 頭頸部癌. 2021.12; 47 (4): 359-365. ( 医中誌 )

360. 原田 浩之. 今求められているNSTと薬剤師の役割　NSTとしての薬剤師の役割 薬事新報. 2021.11; (3227): 7-11. ( 医中誌 )

361. 柴田恵里, 奥山紘平, 道　泰之, 坂本　啓, 原田浩之, 依田哲也. 肺転移に対し外科療法を行った下顎骨原発骨肉腫の1例. 日口外学誌. 2021.06; 67 (6): 353-358. ( DOI 医中誌 )

362. 柴田 恵里, 奥山 紘平, 道 泰之, 坂本 啓, 原田 浩之, 依田 哲也. 肺転移に対し外科療法を行った下顎骨原発骨肉腫の1例 日本口腔外科学会雑誌. 2021.06; 67 (6): 353-358. ( 医中誌 )

363. 家村綾子，柳町昌克，田崎彰久，廣田由佳，大西威一郎，神谷尚宏，津島文彦，原田浩之，木下伊寿美，孝橋賢一，小田義直，高木正稔，明石　巧，朝蔭孝宏，森尾友宏. 出生時から開口障害を認めたデスモイド型線維腫症. 日小児会誌. 2021.04; 125 (4): 619-624. ( 医中誌 )

364. 田中美佐子, 木村宏. ヒストン修飾. 遺伝子医学　MOOK　エピゲノムで新たな解明が進む「先天性疾患」. 2021.04; 36 27-30.

365. 家村 綾子, 柳町 昌克, 田崎 彰久, 廣田 由佳, 大西 威一郎, 神谷 尚宏, 津島 文彦, 原田 浩之, 木下 伊寿美, 孝橋 賢一, 小田 義直, 高木 正稔, 明石 巧, 朝蔭 孝宏, 森尾 友宏. 出生時から開口障害を認めたデスモイド型線維腫症 日本小児科学会雑誌. 2021.04; 125 (4): 619-624. ( 医中誌 )

366. 友澤 潤子, 花房 小百合, 原田 浩之. 苦情のあったチーズにおけるチラミン含有量の調査 滋賀県衛生科学センター所報. 2021.03; 55 30-35. ( 医中誌 )

367. Sakakitani Shintaro, Podyma-Inoue Katarzyna A., Takahashi Kazuki, Harada Hiroyuki, Watabe Tetsuro. Inhibition of oral squamous cell carcinoma progression by targeting β2-adrenergic receptor signals CANCER SCIENCE. 2021.02; 112 360.

368. Okuyama Kohei, Suzuki Keiji, Naruse Tomofumi, Yanamoto Souichi, Umeda Masahiro, Miura Masahiko, Harada Hiroyuki. Potent reduction of cell motility on HNSCC induced by cetuximab demonstrates delayed anti-tumor effect CANCER SCIENCE. 2021.02; 112 649.

369. Inoue Katarzyna A., Sakakitani Shintaro, Takahashi Kazuki, Harada Hiroyuki, Watabe Tetsuro. Novel approach for treatment of oral squamous cell carcinoma CANCER SCIENCE. 2021.02; 112 1040.

370. 高坂　光，平井秀明，及川　悠、大迫利光、釘本琢磨、黒嶋雄志、富岡寛文、島本裕彰、道　泰之、原田浩之. 遊離皮弁の鬱血に対するmedical leech（医療用ヒル）の有効性に関する臨床的検討． 日口外誌. 2020.12; 66 (12): 596-600.

371. 高坂 光, 平井 秀明, 及川 悠, 大迫 利光, 釘本 琢磨, 黒嶋 雄志, 富岡 寛文, 島本 裕彰, 道 泰之, 原田 浩之. 遊離皮弁の鬱血に対するmedical leech(医療用ヒル)の有効性に関する臨床的検討 日本口腔外科学会雑誌. 2020.12; 66 (12): 596-600. ( 医中誌 )

372. 武元　徹, 川野　大, 森　正次, 原田浩之. 悪性高熱症の家族歴を有する患者に対する全身麻酔管理の1 例 有病者歯科医療. 2020.08; 29 (3): 81-86.

373. 武元 徹, 川野 大, 森 正次, 原田 浩之. 悪性高熱症の家族歴を有する患者に対する全身麻酔管理の1例 有病者歯科医療. 2020.08; 29 (3): 81-86. ( 医中誌 )

374. 土橋宏輝, 鳴瀬智史, 奥山紘平, 古川浩平, 柳本惣市, 梅田正博. 放射線性顎骨骨髄炎により広範な皮膚壊死を生じた壊死性筋膜炎の1例  日口診誌. 2020.06; 33 (2): 153-159. ( DOI )

375. 田中美佐子, 富岡寛文, 高原楠旻, 畠山一郎, 坂本　啓, 原田浩之. オトガイ部に発生した結節性筋膜炎の１例 日口外誌. 2020.06; 66 (6): 292-297. ( DOI 医中誌 )

376. Uesugi A., Mochida K., Harada H., Imai H.. Ossifying fibroma arising from the zygomatic arch: A case report JOURNAL OF STOMATOLOGY ORAL AND MAXILLOFACIAL SURGERY. 2020.06; 121 (3): 288-291. ( DOI )

377. 尾田 誠一郎, 森 正次, 原田 浩之. 小児に発症した下顎骨歯原性粘液線維腫の1例 日本口腔内科学会雑誌. 2020.06; 26 (1): 31-35. ( 医中誌 )

378. 田中 美佐子, 富岡 寛文, 高原 楠旻, 畠山 一郎, 坂本 啓, 原田 浩之. オトガイ部に発生した結節性筋膜炎の1例 日本口腔外科学会雑誌. 2020.06; 66 (6): 292-297. ( 医中誌 )

379. Shimamoto Hiroaki, Hirota Yuka, Kashima Yoshihisa, Kinoshita Naoya, Yokokawa Misaki, Ikeda Tohru, Harada Hiroyuki. Granulocyte colony-stimulating factor-producing squamous cell carcinoma of the tongue exhibiting characteristic fluorine-18 deoxyglucose accumulation on positron emission tomography-computed tomography: A case report WORLD JOURNAL OF CLINICAL CASES. 2020.05; 8 (9): 1666-1673.

380. 木村　敦, 平井秀明, 下野宏晃, 坂本　啓, 原田浩之, 依田哲也. 下顎骨関節突起に転移した甲状腺癌の1例 日口外誌. 2020.04; 66 (4): 200-205. ( DOI 医中誌 )

381. 丸川恵理子, 立川敬子, 望月裕美, 高橋幸伸, 原田浩之, 春日井昇平. 巨大な下顎骨エナメル上皮腫摘出後にインプラント治療を行なった1例 顎顔面インプラント誌. 2020.04; 19 (1): 13-18. ( 医中誌 )

382. 木村 敦, 平井 秀明, 下野 宏晃, 坂本 啓, 原田 浩之, 依田 哲也. 下顎骨関節突起に転移した甲状腺癌の1例 日本口腔外科学会雑誌. 2020.04; 66 (4): 200-205. ( 医中誌 )

383. 丸川 恵理子, 立川 敬子, 望月 裕美, 高橋 幸伸, 原田 浩之, 春日井 昇平. 巨大な下顎骨エナメル上皮腫摘出後にインプラント治療を行った1例　11年経過症例 Japanese Journal of Maxillo Facial Implants. 2020.04; 19 (1): 13-18. ( 医中誌 )

384. 西井直人. 口腔多発癌における遺伝子変異プロファイルに基づいた新規診断法の検討 山梨中病年報. 2020.03; 46 126-130.

385. 小井田奈美、西井直人、渡邉峻介、小山敏雄. 口腔扁平上皮癌におけるPolo-like kinase1(Plk1)の発現解析 山梨中病年報. 2020.03; 46 164-167. ( 医中誌 )

386. 小井田奈美、三澤常美、西井直人、高橋幸伸. 当科28年間の悪性腫瘍症例の臨床的検討 山梨中病年報. 2020.03; 46 157-163. ( 医中誌 )

387. Shibutani Shintaro, Obara Hideaki, Matsubara Kentaro, Toya Naoki, Isogai Naoko, Ogino Hidemitsu, Watada Susumu, Asami Atsunori, Kudo Toshifumi, Kanaoka Yuji, Fujimura Naoki, Harada Hirohisa, Uchiyama Hidetoshi, Sato Yasunori, Ohki Takao. Midterm Results of a Japanese Prospective Multicenter Registry of Heparin-Bonded Expanded Polytetrafluoroethylene Grafts for Above-the-Knee Femoropopliteal Bypass CIRCULATION JOURNAL. 2020.03; 84 (3): 501-508. ( PubMed, DOI )

388. 奥山紘平, 柳本惣市, 鳴瀬智史, 梅田正博. 人工透析患者に生じたセフトリアキソン関連脳症の1例 日口診誌. 2020.02; 33 (1): 43-46. ( DOI 医中誌 )

389. 古川浩平, 鳴瀬智史, 奥山紘平, 柳本惣市, 片瀬直樹, 梅田正博. 下顎前歯部に発生した腺性歯原性嚢胞の１例 日口診誌. 2020.02; 33 (1): 61-65. ( DOI 医中誌 )

390. 津島 文彦, 原田 浩之. 歯科の最新テクノロジー　ダチョウ抗体エキス配合剤を用いた口腔ケア　歯周治療への応用と可能性 DENTAL DIAMOND. 2020.02; 45 (3): 94-98. ( 医中誌 )

391. Kaneko Aoi, Marukawa Eriko, Harada Hiroyuki. Hydroxyapatite Nanoparticles as Injectable Bone Substitute Material in a Vertical Bone Augmentation Model IN VIVO. 2020; 34 (3): 1053-1061. ( PubMed, DOI )

392. Shibata Eri, Morita Kei-ichi, Kayamori Kou, Maruiwa Mayuko, Michi Yasuyuki, Sato Yukiko, Takeuchi Kengo, Ikeda Tohru, Harada Hiroyuki, Yoda Tetsuya. Report Secretory carcinoma around Stensen's duct misdiagnosed as salivary duct cyst INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY. 2020; 13 (8): 2211-2217.

393. 福田 修平, 黒嶋 雄志, 富岡 寛文, 及川 悠, 原田 浩之. 長期経過を辿って潜在性頸部リンパ節転移が顕在化した舌扁平上皮癌の3例 日本口腔腫瘍学会誌. 2019.12; 31 (4): 197-202.

394. 福田 修平, 黒嶋 雄志, 富岡 寛文, 及川 悠, 原田 浩之. 長期経過を辿って潜在性頸部リンパ節転移が顕在化した舌扁平上皮癌の3例 日本口腔腫瘍学会誌. 2019.12; 31 (4): 197-202. ( 医中誌 )

395. 尾田 誠一郎, 森 正次, 松下 善彦, 武元 徹, 原田 浩之, 伊東 哲. 先天型筋強直性ジストロフィー患者の全身麻酔下での抜歯経験 有病者歯科医療. 2019.12; 28 (6): 378-383. ( 医中誌 )

396. Mochizuki Yumi, Harada Hiroyuki, Oyama Jun, Sakamoto Kei, Michi Yasuyuki, Kuroshima Takeshi, Kugimoto Takuma. Metastatic gastric adenocarcinoma of the tongue with initial symptoms of glossodynia CURRENT PROBLEMS IN CANCER. 2019.12; 43 (6): 100481. ( PubMed, DOI )

397. 本多奈津子, 道 泰之, 友松伸允, 石田尚子, 坂本 啓, 山口聰. 硬化性歯原性癌の1例. 日本口腔外科学会雑誌. 2019.11; 65 (11): 708-713.

398. 炭野淳, 柴田真理, 八木原一博, 石田尚子, 道 泰之, 依田哲也.. 下唇に生じた唾石を伴う粘液嚢胞の1例. 日本口腔外科学会雑誌. 2019.11; 65 (11): 708-713.

399. 佐藤 潔, 松下 善彦, 木村 敦, 小井田 奈美, 栢森 高, 池田 通, 森 正次, 原田 浩之. 口腔に発生した顆粒細胞腫19例の臨床病理組織学的検討　脈管侵襲について 日本口腔外科学会雑誌. 2019.10; 65 (10): 645-650. ( 医中誌 )

400. 津島文彦，原田浩之. 歯科・口腔外科領域　この5年の進歩 内科. 2019.09; 124 (3): 2002-2003.

401. 尾田誠一郎，森　正次，松下善彦，原田浩之. 頬粘膜に生じた成人型黄色肉芽腫の1例 日本口腔外科学会雑誌. 2019.09; 65 (9): 587-592.

402. 尾田 誠一郎, 森 正次, 松下 善彦, 原田 浩之. 頬粘膜に生じた成人型黄色肉芽腫の1例 日本口腔外科学会雑誌. 2019.09; 65 (9): 587-592. ( 医中誌 )

403. 津島 文彦, 原田 浩之. 【内科医に求められる他科の知識-専門家が伝えるDo/Don't】(第10章)歯科・口腔外科　歯科・口腔外科領域　この5年の進歩 内科. 2019.09; 124 (3): 2002-2003. ( 医中誌 )

404. 樋口佑輔,樺沢勇司,富岡寛文,林　駿哉,土谷麻衣子,原田浩之. 下顎骨に発生した毛細血管奇形の1例 日本口腔外科学会雑誌. 2019.08; 65 (8): 557-562.

405. 樋口 佑輔, 樺沢 勇司, 富岡 寛文, 林 駿哉, 土谷 麻衣子, 原田 浩之. 下顎骨に発生した毛細血管奇形の1例 日本口腔外科学会雑誌. 2019.08; 65 (8): 557-562. ( 医中誌 )

406. 平山超教、富岡寛文、小野里祐佑、高原楠旻、丸川恵理子、原田浩之. 口底に発生した神経内分泌癌の1例 日本口腔外科学会雑誌. 2019.07; 65 (7): 455-460.

407. Komiya Ruri, Wada Takahiro, Tsushima Fumihiko, Sakamoto Kei, Ikeda Tohru, Yamaguchi Akira, Harada Hiroyuki, Uo Motohiro. Quantitation and distribution of metallic elements in sequestra of medication-related osteonecrosis of jaw (MRONJ) using inductively coupled plasma atomic emission spectroscopy and synchrotron radiation X-ray fluorescence analysis JOURNAL OF BONE AND MINERAL METABOLISM. 2019.07; 37 (4): 676-684. ( PubMed, DOI )

408. 平山 超教, 富岡 寛文, 小野里 祐佑, 高原 楠旻, 丸川 恵理子, 原田 浩之. 口底に発生した神経内分泌癌の1例 日本口腔外科学会雑誌. 2019.07; 65 (7): 455-460. ( 医中誌 )

409. Furusawa Yoshikazu, Yamada Shinji, Nakamura Takuro, Sano Masato, Sayama Yusuke, Itai Shunsuke, Takei Junko, Harada Hiroyuki, Fukui Masato, Kaneko Mika K., Kato Yukinari. PMab-235: A monoclonal antibody for immunohistochemical analysis against goat podoplanin HELIYON. 2019.07; 5 (7): e02063. ( PubMed, DOI )

410. 中川知里，津島文彦，櫻井仁亨，上杉篤史，佐藤　潔，尾田誠一郎，原田浩之. 類天疱瘡24例に関する臨床病理学的検討 日本口腔内科学会雑誌. 2019.06; 25 (1): 1-9.

411. 小井田奈美、櫻井仁亨、道川千絵子、依田哲也、坂本　啓、原田浩之. 同種骨髄移植後にサイトメガロウィルス感染を伴う口内炎を発症した1例 日本口腔外科学会雑誌. 2019.06; 65 (6): 194-198.

412. 上杉篤史、津島文彦、清水梨沙、中川知里、佐藤　潔、櫻井仁亨、原田浩之. 口内炎を契機に診断された第二期梅毒の1例 日本口腔内科学会雑誌. 2019.06; 25 (1): 16-19.

413. 上杉 篤史, 津島 文彦, 清水 梨沙, 中川 知里, 佐藤 潔, 櫻井 仁亨, 原田 浩之. 口内炎を契機に診断された第二期梅毒の1例 日本口腔内科学会雑誌. 2019.06; 25 (1): 16-19. ( 医中誌 )

414. 中川 知里, 津島 文彦, 櫻井 仁亨, 上杉 篤史, 佐藤 潔, 尾田 誠一郎, 原田 浩之. 類天疱瘡24例に関する臨床病理学的検討 日本口腔内科学会雑誌. 2019.06; 25 (1): 1-9. ( 医中誌 )

415. 小井田 奈美, 櫻井 仁亨, 道川 千絵子, 依田 哲也, 坂本 啓, 原田 浩之. 同種骨髄移植後にサイトメガロウイルス感染を伴う口内炎を発症した1例 日本口腔外科学会雑誌. 2019.06; 65 (6): 412-418. ( 医中誌 )

416. 三浦千佳, 道 泰之, 道川千絵子, 福井 怜, 栢森 高, 山口 聰. 舌尖部に生じた嚢胞腺癌の1例. 日本口腔外科学会雑誌. 2019.05; 65 (5): 323-327.

417. Minegishi Saki, Ohtani Susumu, Noritake Kanako, Funakoshi Takeshi, Ishii Namiko, Utsuno Hajime, Sakuma Ayaka, Saitoh Hisako, Yamaguchi Satoshi, Marukawa Eriko, Harada Hiroyuki, Uemura Koichi, Sakurada Koichi. Preparation of dentin standard samples for age estimation based on increased aspartic acid racemization rate by heating LEGAL MEDICINE. 2019.05; 38 25-31. ( PubMed, DOI )

418. 原田 浩之, 富岡 寛文, 横川 美咲, 野島 瞳, 小宮 瑠里, 栢森 高, 池田 通, 倉林 亨. 新TNM分類(第8版)の改定点と問題点　舌癌における新T分類(UICC第8版)に導入された深達度(DOI)評価　標本収縮を考慮した病理組織学的DOIと臨床的DOI評価の検討 頭頸部癌 . 2019.04; 45 (1): 1-7. ( DOI 医中誌 )

419. Oshibe Narumi, Marukawa Eriko, Yoda Tetsuya, Harada Hiroyuki. Degradation and interaction with bone of magnesium alloy WE43 implants: A long-term follow-up in vivo rat tibia study JOURNAL OF BIOMATERIALS APPLICATIONS. 2019.04; 33 (9): 1157-1167. ( PubMed, DOI )

420. 原田 浩之, 富岡 寛文, 横川 美咲, 野島 瞳, 小宮 瑠里, 栢森 高, 池田 通, 倉林 亨. 新TNM分類(第8版)の改定点と問題点　舌癌における新T分類(UICC第8版)に導入された深達度(DOI)評価　標本収縮を考慮した病理組織学的DOIと臨床的DOI評価の検討 頭頸部癌. 2019.04; 45 (1): 1-7. ( 医中誌 )

421. 新垣理宣, 中村 伸, 道 泰之，依田哲也，倉林 亨. 急速な下顎骨破壊を示した多発性骨髄腫の画像所見 歯科放射線. 2019.03; 58 (2): 86-88.

422. 上杉 篤史, 津島 文彦, 横川 美咲, 及川 悠, 望月 裕美, 原田 浩之. 難治性口腔潰瘍を契機として腸管ベーチェット病疑いに至った1例 日本口腔外科学会雑誌. 2019.03; 65 (3): 194-198. ( 医中誌 )

423. 濱本 正太郎, 富岡 寛文, 横川 美咲, 生田 稔, 坂本 啓, 原田 浩之. 多発性骨髄腫に移行した下顎骨孤立性形質細胞腫の1例 日本口腔外科学会雑誌. 2019.02; 65 (2): 110-114. ( DOI 医中誌 )

424. Ishida Shoko, Kayamori Kou, Sakamoto Kei, Yukimori Akane, Kugimoto Takuma, Harada Hiroyuki, Ikeda Tohru. <i>Alpha-L-fucosidase-1</i> is a diagnostic marker that distinguishes mucoepidermoid carcinoma from squamous cell carcinoma PATHOLOGY INTERNATIONAL. 2019.02; 69 (2): 76-85. ( PubMed, DOI )

425. Sato Kiyoshi, Shimamoto Hiroaki, Mochizuki Yumi, Hirai Hideaki, Tomioka Hirofumi, Shimizu Risa, Marukawa Eriko, Fukayama Haruhisa, Yoshimura Ryoichi, Ishida Hiroo, Harada Hiroyuki. Treatment of oral cancers during pregnancy: a case-based discussion JOURNAL OF OTOLARYNGOLOGY-HEAD & NECK SURGERY. 2019.02; 48 (1): 9. ( PubMed, DOI )

426. 濱本 正太郎, 富岡 寛文, 横川 美咲, 生田 稔, 坂本 啓, 原田 浩之. 多発性骨髄腫に移行した下顎骨孤立性形質細胞腫の1例 日本口腔外科学会雑誌. 2019.02; 65 (2): 110-114. ( 医中誌 )

427. Fukuda Shuhei, Akiyama Masako, Harada Hiroyuki, Nakahama Ken-ichi. Effect of gap junction-mediated intercellular communication on TGF-β induced epithelial-to-mesenchymal transition2 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 2019.01; 508 (3): 928-933. ( PubMed, DOI )

428. Itai Shunsuke, Ohishi Tomokazu, Kaneko Mika, Yamada Shinji, Abe Shinji, Nishioka Yasuhiko, Kawada Manabu, Harada Hiroyuki, Kato Yukinari. Antitumor activity by ADCC against oral squamous cell carcinomas by anti-podocalyxin antibody CANCER SCIENCE. 2018.12; 109 269.

429. Takagawa Yuki, Gen Yasuyuki, Muramatsu Tomoki, Harada Hiroyuki, Inazawa Johji. Exploring novel tumor suppressive microRNAs in OSCC CANCER SCIENCE. 2018.12; 109 1083.

430. Takahashi Yukinobu, Tanaka Kae, Hirai Hideaki, Marukawa Eriko, Izumo Toshiyuki, Harada Hiroyuki. Appropriate surgical margin for odontogenic myxoma: a review of 12 cases ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY. 2018.11; 126 (5): 404-408. ( PubMed, DOI )

431. 津島 文彦, 原田 浩之. 【口腔疾患と慢性炎症】口腔領域における特異性炎 別冊Bio Clinica: 慢性炎症と疾患. 2018.10; 7 (3): 65-69. ( 医中誌 )

432. 野島　瞳，富岡寛文，大迫利光，津島文彦，池田　通，原田浩之. 病理組織標本作成過程における組織の寸法変化に関する検討 日本口腔科学会雑誌. 2018.09; 67 (3): 240-245.

433. 野島 瞳, 富岡 寛文, 大迫 利光, 津島 文彦, 池田 通, 原田 浩之. 病理組織標本作製過程における組織の寸法変化に関する検討 日本口腔科学会雑誌. 2018.09; 67 (3): 240-245. ( 医中誌 )

434. 丸川恵理子. 骨造成のための移植材料：HAp ／コラーゲンスポンジ（リフィット®） Journal of Bio-Integration. 2018.08; 8 9-14.

435. Matsui Toshihiro, Okada Takuya, Kawada Kenro, Okuda Masahumi, Ogo Taichi, Nakajima Yutaka, Kume Yuichiro, Ryotokuji Tairo, Hoshino Akihiro, Tokairin Yutaka, Michi Yasuyuki, Harada Hiroyuki, Nakajima Yasuaki, Kawano Tatsuyuki. Detection of Second Primary Malignancies of the Esophagus and Hypophraynx in Oral Squamous Cell Carcinoma Patients LARYNGOSCOPE INVESTIGATIVE OTOLARYNGOLOGY. 2018.08; 3 (4): 263-267. ( PubMed, DOI )

436. 髙橋幸伸，今井英樹，持田薫利，角倉可奈子，原田浩之. 成人の顎下部に発生した嚢胞状リンパ管腫の1例 日本口腔外科学会雑誌. 2018.07; 64 (7): 418-422.

437. 津島 文彦，原田 浩之. 口腔領域における特異性炎 別冊Bio Clinica 口腔疾患と慢性炎症. 2018.07; 7 (3): 65-69.

438. 高橋 幸伸, 今井 英樹, 持田 薫利, 角倉 可奈子, 原田 浩之. 成人の顎下部に発生した嚢胞状リンパ管腫の1例 日本口腔外科学会雑誌. 2018.07; 64 (7): 418-422. ( 医中誌 )

439. Yamaga Emi, Toriihara Akira, Nakamura Shin, Asai Sakurako, Fujioka Tomoyuki, Yoshimura Ryoichi, Michi Yasuyuki, Harada Hiroyuki, Tateishi Ukihide. Clinical usefulness of 2-deoxy-2-[<SUP>18</SUP>F]fluoro-D-glucose-positron emission tomography/ computed tomography for assessing early oral squamous cell carcinoma (cT1-2N0M0) JAPANESE JOURNAL OF CLINICAL ONCOLOGY. 2018.07; 48 (7): 633-639. ( PubMed, DOI )

440. Nishii N., Tachinami H., Kondo Y., Xia Y., Kashima Y., Ohno T., Nagai S., Li L., Lau W., Harada H., Azuma M.. Systemic administration of a TLR7 agonist attenuates regulatory T cells by dendritic cell modification and overcomes resistance to PD-L1 blockade therapy EUROPEAN JOURNAL OF IMMUNOLOGY. 2018.05; 48 71-72.

441. 丸岡　豊. HIV/AIDSの口腔内所見と歯科治療状の注意点 日本歯科医学会雑誌. 2018.04; 11-14.

442. 原田浩之. Q&A.BP製剤内服患者の抜歯時、肉芽は残すべきか否か。 DENTAL DIAMOND. 2018.02; 43 (629): 118-119.

443. 原田浩之. 地図状舌の治療 ドクターサロン. 2018.02; 62 (2): 29-33.

444. 原田 浩之. BP製剤内服患者の抜歯時、肉芽は残すべきか否か DENTAL DIAMOND. 2018.02; 43 (3): 118-119. ( 医中誌 )

445. 小林 博美, 宮下 康雄, 原田 浩之. 滋賀県における環境放射能水準調査結果(平成26～28年度) 滋賀県衛生科学センター所報. 2018.02; 52 59-65. ( 医中誌 )

446. Harada Haruhito, Hayashi Takeharu, Nishi Hirofumi, Kusaba Ken, Koga Yoshinori, Koga Yasutoshi, Nonaka Ikuya, Kimura Akinori. Phenotypic expression of a novel desmin gene mutation: hypertrophic cardiomyopathy followed by systemic myopathy JOURNAL OF HUMAN GENETICS. 2018.02; 63 (2): 249-254. ( PubMed, DOI )

447. 原田浩之. 口腔癌における選択的頸部郭清術 日本口腔外科学会雑誌. 2018.01; 64 8-12.

448. 原田浩之. 知っておきたい口内炎の知識 けあ・ふる. 2018.01; 94 2-4.

449. 原田浩之. 口腔癌における選択的頸部郭清術 日本口腔外科学会雑誌. 2018.01; 64 (1): 8-12. ( DOI )

450. 依田　泰. ノーベル・バイオケア・コニカルコネクション・インプラントの臨床応用 インプラント YEAR BOOK 2018. 2018.01; 253-260.

451. Itai Shunsuke, Yamada Shinji, Kaneko Mika K., Chang Yao-Wen, Kunita Akiko, Fukayama Masashi, Harada Hiroyuki, Kato Yukinari. PcMab-47: a novel anti-human podocalyxin monoclonal antibody for immunohistochemistry against oral cancers CANCER SCIENCE. 2018.01; 109 1052.

452. 原田 浩之. 口腔癌における選択的頸部郭清術 日本口腔外科学会雑誌. 2018.01; 64 (1): 8-12. ( 医中誌 )

453. 平井秀明，横川美咲，及川　悠，大迫利光，望月裕美，田中香衣，富岡寛文，島本裕彰，原田浩之. 後期高齢者口腔扁平上皮癌症例の臨床的検討 日本口腔腫瘍学会誌. 2017.12; 29 158-164.

454. 道　泰之，原田浩之. 組織型から考える 日本口腔腫瘍学会誌. 2017.12; 29(4) 206-211.

455. Elbashti ME, Aswehlee AM, Hattori M, Sumita Y, Michi Y, Uzawa N, Yamaguchi S, Harada H, Taniguchi H. Surgions’ awarenesss of the considerations for prosthetic rehabilitation in maxillectomy patients 日本顎顔面補綴学会誌. 2017.12; 40(2) 12-20.

456. 平井 秀明, 横川 美咲, 及川 悠, 大迫 利光, 望月 裕美, 田中 香衣, 富岡 寛文, 島本 裕彰, 原田 浩之. 高齢者口腔癌治療の実際と今後の方向性　後期高齢者口腔扁平上皮癌症例の臨床的検討 日本口腔腫瘍学会誌. 2017.12; 29 (4): 158-164. ( 医中誌 )

457. 道 泰之, 原田 浩之. 口腔がん手術の適応を考える　組織型から考える 日本口腔腫瘍学会誌. 2017.12; 29 (4): 206-211. ( 医中誌 )

458. 大迫利光，今井雄太，松川　祥，持田薫利，原田浩之，三澤常美. 下顎歯肉悪性黒色腫に対するNivolumabの使用経験 日本口腔外科学会雑誌. 2017.11; 63 (11): 558-563.

459. 大迫 利光, 今井 雄太, 松川 祥, 持田 薫利, 原田 浩之, 三澤 常美. 下顎歯肉悪性黒色腫に対するNivolumabの使用経験 日本口腔外科学会雑誌. 2017.11; 63 (11): 558-563. ( 医中誌 )

460. 坂本潤一郎，小滝真也，中村 伸，角倉可奈子，原田浩之，倉林 亨. 上顎に生じた歯原性幻影細胞癌の 1 例 歯科放射線. 2017.10; 57 (1): 57-59.

461. Yamagata Yuko, Tomioka Hirofumi, Sakamoto Kei, Sato Kiyoshi, Harada Hiroyuki, Ikeda Tohru, Kayamori Kou. CD163-Positive Macrophages Within the Tumor Stroma Are Associated With Lymphangiogenesis and Lymph Node Metastasis in Oral Squamous Cell Carcinoma JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY. 2017.10; 75 (10): 2144-2153. ( PubMed, DOI )

462. 坂本 潤一郎, 小滝 真也, 中村 伸, 角倉 可奈子, 原田 浩之, 倉林 亨. 上顎に生じた歯原性幻影細胞癌の1例 歯科放射線. 2017.09; 57 (1): 57-59. ( 医中誌 )

463. Shimamoto Hiroaki, Oikawa Yu, Osako Toshimitsu, Hirai Hideaki, Mochizuki Yumi, Tanaka Kae, Tomioka Hirofumi, Harada Hiroyuki. Neck failure after elective neck dissection in patients with oral squamous cell carcinoma ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY. 2017.07; 124 (1): 32-36. ( PubMed, DOI )

464. 小枝聡子，日原大貴，菅野彰剛，川島隆太，中里信和. 大口蓋神経および舌神経電気刺激における大脳皮質反応の初期成分 日本生体磁気学誌. 2017.05; 30 (1): 170-171.

465. 原田浩之. インフォームドコンセントの変遷 日本口腔外科学会雑誌. 2017.05; 63 (5): 241.

466. 原田浩之. 遅れて生えてくる親知らず 学校保健ニュース高校版 インタープレス. 2017.05; 1748

467. 原田浩之. トラブルを起こしやすい親知らず 学校保健ニュース高校版. 2017.05; 1746 6-7.

468. Onozato Yusuke, Kaida Atsushi, Harada Hiroyuki, Miura Masahiko. Radiosensitivity of quiescent and proliferating cells grown as multicellular tumor spheroids CANCER SCIENCE. 2017.04; 108 (4): 704-712. ( PubMed, DOI )

469. 隅田 由香, 原口 美穂子, 服部 麻里子, 乙丸 貴史, 村瀬 舞, 吉 志元, 山口 聡, 原田 浩之, 谷口 尚. イミディエイトサージカルオブチュレータ(ISO)製作のコンセプトについて 頭頸部癌. 2017.04; 43 (1): 95-99. ( 医中誌 )

470. 島本 裕彰，原田 浩之. 口腔がん薬物療法の進歩 口腔病学会雑誌. 2017.03; 84 (1):

471. 丸岡　豊. 特集　糖尿病、高血圧etc,持病のあるかた　歯科受診にもお薬手帳を忘れずに！ nico. 2017.03; 10-23.

472. 島本 裕彰, 原田 浩之. 最近の歯学　顎口腔外科　口腔がん薬物療法の進歩 口腔病学会雑誌. 2017.03; 84 (1): 46. ( 医中誌 )

473. 上杉篤史、櫻井仁亨、津島文彦、佐藤　昌、松本佳奈子、原田浩之. 上下顎歯肉に生じたPlasma cell gingivitisの1例 日本口腔外科学会雑誌. 2017.02; 63 (2):

474. 上杉 篤史, 櫻井 仁亨, 津島 文彦, 佐藤 昌, 松本 佳奈子, 原田 浩之. 上下顎歯肉に生じたPlasma cell gingivitisの1例 日本口腔外科学会雑誌. 2017.02; 63 (2): 69-73. ( 医中誌 )

475. Oikawa Yu, Morita Kei-ichi, Kayamori Kou, Tanimoto Kousuke, Sakamoto Kei, Katoh Hiroto, Ishikawa Shumpei, Inazawa Johji, Harada Hiroyuki. Receptor tyrosine kinase amplification is predictive of distant metastasis in patients with oral squamous cell carcinoma CANCER SCIENCE. 2017.02; 108 (2): 256-266. ( PubMed, DOI )

476. 隅田由香，原口美穂子，服部麻里子，乙丸貴史，村瀬　舞，吉　志元，山口　聡，原田浩之，谷口　尚. イミディエイトサージカルオブチュレーター（ISO）製作のコンセプトについて 頭頸部癌. 2017.01; 43 (1): 95-99.

477. 原田浩之. 歯医者さんの専門分野別Q&A 頼りになるいい歯医者さん2017. 2017; 116-119.

478. 小野里祐佑，富岡寛文，高原楠旻，大迫利光，原田浩之. 本態性血小板血症患者に発生した舌癌の1例 日本口腔外科学会雑誌. 2016.09; 62 (9): 460-465.

479. 武元 徹, 樺沢勇司, 津島文彦, 平井秀明, 小村 健, 原田浩之. 顎関節部に生じた慢性拡張性血種の1例 日本口腔外科学会雑誌. 2016.09; 62 (9): 454-459.

480. 原田浩之. 口腔内の異変　放置しないで 日本経済新聞. 2016.05;

481. 高原楠旻，中川　聡，角倉可奈子，今井英樹，原田浩之. 下顎骨関節突起骨折治療後に生じた顎関節強直症の 3 例 日本顎関節学会雑誌. 2016.04; 28 (1): 28-34.

482. 依田　泰. 下顎前歯部単独歯欠損にナローインプラントを応用する際のポイント Quintessence DENTAL Implantology. 2016.03; 23 (2): 24-29.

483. 原田浩之. 全身合併症を有する患者に対する遊離皮弁術 口腔外科ハンドマニュアル’16 . 2016; 254-258.

484. 依田　泰. 臼歯部におけるノーベルプロセラASCジルコニアアバットメントおよびノーベルプロセラFCZインプラントクラウンの有用性 Quintessenceインプラント YEAR BOOK 2016. 2016; 235-242.

485. 原口美穂子，道　泰之，田中顕太郎，原田浩之，隅田由香，原田　清，岡崎　睦，谷口　尚. 口腔癌切除後の口腔形態の改善を目指した補助装置―ステントの2症例― 頭頸部癌. 2016; 42 (1): 13-20.

486. 原田浩之. 口腔癌における頸部制御に対する治療戦略 口腔病学会雑誌. 2016; 83 (1): 1-6.

487. 津島 文彦，桜井 仁亨，松本 佳奈子，上杉 篤史，佐藤 昌，尾田 誠一郎，原田 浩之. 腸管ベーチェット病が疑われた再発性アフタ性潰瘍の1例 日本口腔内科学会雑誌. 2015.12; 21 (2): 43-48.

488. 丸川 恵理子. MRONJ診断と治療の最前線「MRONJ研究の最前線」 デンタルダイヤモンド10月号. 2015.10; 40 (13): 44-47.

489. 富岡 寛文. MRONJ診断と治療の最前線「BP製剤・抗RANKL抗体・抗VEGF抗体使用患者への歯科的対応」 デンタルダイヤモンド10月号. 2015.10; 40 (13): 34-38.

490. 原田 浩之. MRONJ診断と治療の最前線「歯科医師に求められるMRONJの知識と対応」 デンタルダイヤモンド10月号. 2015.10; 40 (13): 28-33.

491. 丸川 恵理子. 上顎洞底挙上術における自家骨の必要性 バイオインテグレーション学会誌 . 2015.10; 5 35-39.

492. 樺沢 勇司. MRONJ診断と治療の最前線「MRONJに対する治療法」 デンタルダイヤモンド10月号. 2015.10; 40 (13): 39-51.

493. 中川 聡, 高原 楠旻, 角倉 可奈子, 今井 英樹, 小村 健. 急性非復位性関節円板前方転位に対する関節円板復位療法の適応に関する臨床的検討 日本顎関節学会雑誌. 2015.08; 27 (2): 93-102.

494. 小村 健, 原田 浩之, 生田 稔, 島本 裕彰, 富岡 寛文, 釘本 琢磨. 進行口腔原発巣再発癌（rT3，rT4）に対する救済手術 日本口腔腫瘍学会誌. 2014.12; 26 (4): 132-139. ( DOI )

495. 森 正次, 樋口 佑輔, 相澤 悟. 2次性メトヘモグロビン血症の既往を持つ患者の抜歯の1例 日本口腔診断学会雑誌. 2014.10; 27 (3): 307-310. ( 医中誌 )

496. 釘本 琢磨, 小村 健, 田中 香衣, 富岡 寛文, 島本 裕彰, 原田 浩之. PGAシートとフィブリン糊併用の有茎頬脂肪体による上顎部分切除後の上顎・口蓋再建 日本口腔外科学会雑誌. 2014.09; 60 (9): 527-531. ( 医中誌 )

497. 原田 浩之, 小村 健, 島本 裕彰. 口腔扁平上皮癌における選択的頸部郭清術 頭頸部癌. 2014.04; 40 (1): 16-22. ( 医中誌 )

498. 田口 貴英. 口腔扁平上皮癌におけるEGFレセプターの核内移行と臨床病理学的因子との関連 口腔病学会雑誌. 2014.03; 81 (1): 45-52. ( 医中誌 )

499. 工藤 雅範, 原田 浩之, 津島 文彦, 松本 佳奈子, 小村 健, 石井 良昌. 上顎洞を広範に占拠した内反乳頭腫の1例 日本口腔外科学会雑誌. 2014.01; 60 (1): 29-33. ( 医中誌 )